If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
<br /> VOLUME 29 | SUPPLEMENT 2 | FEBRUARY 2016<br /> MODERN PATHOLOGY<br /> NEXTGENERATIONLEARNING<br /> 105THANNUALMEETING<br /> March 12-18, 2016<br /> Washington State Convention Center<br /> Seattle, Washington<br /> ABSTRACTS<br /> The largest gathering of pathologists in the world<br /> The largest number of onsite scientific abstract presentations<br /> in anatomic and molecular diagnostic pathology<br /> USCAP is Building its Future and Yours<br /> Powers-Sanchez<br /> Interactive Center<br /> NOW OPEN<br /> Two lab spaces, each with an 18-head<br /> teaching microscope and 17 individual<br /> personal microscopes<br /> Year-round sessions in all subspecialties<br /> of anatomic pathology taught by expert<br /> pathologists<br /> Ultrasound equipment for interventional cytology<br /> High definition digital camera with telepathology<br /> software<br /> Linder<br /> Learning Center<br /> OPENING SPRING 2016<br /> Broadcast television studi<a title="MPATH_Vol.29_Supplement2 page 1" href="http://viewer.zmags.com/publication/916a99fc?page=1"> VOLUME 29 | SUPPLEMENT 2 | FEBRUARY 2016 MODERN P</a> <a title="MPATH_Vol.29_Supplement2 page 2" href="http://viewer.zmags.com/publication/916a99fc?page=2"> USCAP is Building its Future and Yours Powers-San</a> <a title="MPATH_Vol.29_Supplement2 page 3" href="http://viewer.zmags.com/publication/916a99fc?page=3"> USCAP is all around you. Take it in. </a> <a title="MPATH_Vol.29_Supplement2 page 4" href="http://viewer.zmags.com/publication/916a99fc?page=4"> Your Passport to Becoming a Better Pathologi</a> <a title="MPATH_Vol.29_Supplement2 page 5" href="http://viewer.zmags.com/publication/916a99fc?page=5"> ABSTRACTS 105th Annual Meeting United State</a> <a title="MPATH_Vol.29_Supplement2 page 6" href="http://viewer.zmags.com/publication/916a99fc?page=6"> United States & Canadian Academy of Pathology </a> <a title="MPATH_Vol.29_Supplement2 page 7" href="http://viewer.zmags.com/publication/916a99fc?page=7"> TABLE OF CONTENTS The abstracts are grouped in c</a> <a title="MPATH_Vol.29_Supplement2 page 8" href="http://viewer.zmags.com/publication/916a99fc?page=8"> 4A </a> <a title="MPATH_Vol.29_Supplement2 page 9" href="http://viewer.zmags.com/publication/916a99fc?page=9"> ANNUAL MEETING ABSTRACTS Design: 5 study groups, </a> <a title="MPATH_Vol.29_Supplement2 page 10" href="http://viewer.zmags.com/publication/916a99fc?page=10"> 6A No. Age/Sex Presentation 1 72/M </a> <a title="MPATH_Vol.29_Supplement2 page 11" href="http://viewer.zmags.com/publication/916a99fc?page=11"> ANNUAL MEETING ABSTRACTS neck, thorax and superio</a> <a title="MPATH_Vol.29_Supplement2 page 12" href="http://viewer.zmags.com/publication/916a99fc?page=12"> 8A The placenta demonstrated </a> <a title="MPATH_Vol.29_Supplement2 page 13" href="http://viewer.zmags.com/publication/916a99fc?page=13"> ANNUAL MEETING ABSTRACTS </a> <a title="MPATH_Vol.29_Supplement2 page 14" href="http://viewer.zmags.com/publication/916a99fc?page=14"> 10A work, we will utilize this valuable resource </a> <a title="MPATH_Vol.29_Supplement2 page 15" href="http://viewer.zmags.com/publication/916a99fc?page=15"> ANNUAL MEETING ABSTRACTS of which can cause or co</a> <a title="MPATH_Vol.29_Supplement2 page 16" href="http://viewer.zmags.com/publication/916a99fc?page=16"> 12A inflammation with necrosis (n=23, group 2), a</a> <a title="MPATH_Vol.29_Supplement2 page 17" href="http://viewer.zmags.com/publication/916a99fc?page=17"> ANNUAL MEETING ABSTRACTS 36 Fibrous Hamarto</a> <a title="MPATH_Vol.29_Supplement2 page 18" href="http://viewer.zmags.com/publication/916a99fc?page=18"> 14A Conclusions: Our data suggest that TERT promo</a> <a title="MPATH_Vol.29_Supplement2 page 19" href="http://viewer.zmags.com/publication/916a99fc?page=19"> ANNUAL MEETING ABSTRACTS 43 Extraosseous, E</a> <a title="MPATH_Vol.29_Supplement2 page 20" href="http://viewer.zmags.com/publication/916a99fc?page=20"> 16A EWSR1-ERG fusion, where FISH assay did not de</a> <a title="MPATH_Vol.29_Supplement2 page 21" href="http://viewer.zmags.com/publication/916a99fc?page=21"> ANNUAL MEETING ABSTRACTS Conclusions: Recurrent m</a> <a title="MPATH_Vol.29_Supplement2 page 22" href="http://viewer.zmags.com/publication/916a99fc?page=22"> 18A Results: Fourteen GCTs (93.3%) presented a mu</a> <a title="MPATH_Vol.29_Supplement2 page 23" href="http://viewer.zmags.com/publication/916a99fc?page=23"> ANNUAL MEETING ABSTRACTS 61 Clinical and Pa</a> <a title="MPATH_Vol.29_Supplement2 page 24" href="http://viewer.zmags.com/publication/916a99fc?page=24"> 20A absent in all others. Histologically, URCS wi</a> <a title="MPATH_Vol.29_Supplement2 page 25" href="http://viewer.zmags.com/publication/916a99fc?page=25"> ANNUAL MEETING ABSTRACTS Conclusions: It is feasi</a> <a title="MPATH_Vol.29_Supplement2 page 26" href="http://viewer.zmags.com/publication/916a99fc?page=26"> 22A immunohistochemical evaluation of ETV4, even </a> <a title="MPATH_Vol.29_Supplement2 page 27" href="http://viewer.zmags.com/publication/916a99fc?page=27"> ANNUAL MEETING ABSTRACTS Design: Sarcomas cases i</a> <a title="MPATH_Vol.29_Supplement2 page 28" href="http://viewer.zmags.com/publication/916a99fc?page=28"> 24A and predictive value. The main criteria of se</a> <a title="MPATH_Vol.29_Supplement2 page 29" href="http://viewer.zmags.com/publication/916a99fc?page=29"> ANNUAL MEETING ABSTRACTS (n-terminus). Five patie</a> <a title="MPATH_Vol.29_Supplement2 page 30" href="http://viewer.zmags.com/publication/916a99fc?page=30"> 26A Functional suppression of PDC activity is a r</a> <a title="MPATH_Vol.29_Supplement2 page 31" href="http://viewer.zmags.com/publication/916a99fc?page=31"> ANNUAL MEETING ABSTRACTS Conclusions: The NGS pan</a> <a title="MPATH_Vol.29_Supplement2 page 32" href="http://viewer.zmags.com/publication/916a99fc?page=32"> 28A Breast Pathology 101 Overexpression of </a> <a title="MPATH_Vol.29_Supplement2 page 33" href="http://viewer.zmags.com/publication/916a99fc?page=33"> ANNUAL MEETING ABSTRACTS 104 Epithelial-Mese</a> <a title="MPATH_Vol.29_Supplement2 page 34" href="http://viewer.zmags.com/publication/916a99fc?page=34"> 30A Design: An electronic database search (2007-2</a> <a title="MPATH_Vol.29_Supplement2 page 35" href="http://viewer.zmags.com/publication/916a99fc?page=35"> ANNUAL MEETING ABSTRACTS Age Salient gross featur</a> <a title="MPATH_Vol.29_Supplement2 page 36" href="http://viewer.zmags.com/publication/916a99fc?page=36"> 32A Conclusions: FNA using ThinPrep alone has acc</a> <a title="MPATH_Vol.29_Supplement2 page 37" href="http://viewer.zmags.com/publication/916a99fc?page=37"> ANNUAL MEETING ABSTRACTS for symptomatic relief o</a> <a title="MPATH_Vol.29_Supplement2 page 38" href="http://viewer.zmags.com/publication/916a99fc?page=38"> 34A staining, weak/focal staining, and strong/dif</a> <a title="MPATH_Vol.29_Supplement2 page 39" href="http://viewer.zmags.com/publication/916a99fc?page=39"> ANNUAL MEETING ABSTRACTS 129 Ductal Carcinom</a> <a title="MPATH_Vol.29_Supplement2 page 40" href="http://viewer.zmags.com/publication/916a99fc?page=40"> 36A regression with age and year of biopsy as adj</a> <a title="MPATH_Vol.29_Supplement2 page 41" href="http://viewer.zmags.com/publication/916a99fc?page=41"> ANNUAL MEETING ABSTRACTS All cases showed papilla</a> <a title="MPATH_Vol.29_Supplement2 page 42" href="http://viewer.zmags.com/publication/916a99fc?page=42"> 38A therapy. MpVMC accounts for <10% of the MBC d</a> <a title="MPATH_Vol.29_Supplement2 page 43" href="http://viewer.zmags.com/publication/916a99fc?page=43"> ANNUAL MEETING ABSTRACTS 145 Nuclear Grading</a> <a title="MPATH_Vol.29_Supplement2 page 44" href="http://viewer.zmags.com/publication/916a99fc?page=44"> 40A Conclusions: In our cohor</a> <a title="MPATH_Vol.29_Supplement2 page 45" href="http://viewer.zmags.com/publication/916a99fc?page=45"> ANNUAL MEETING ABSTRACTS 2 (<1%) amplified to equ</a> <a title="MPATH_Vol.29_Supplement2 page 46" href="http://viewer.zmags.com/publication/916a99fc?page=46"> 42A 157 Increased HER2 FISH-IHC Discordance </a> <a title="MPATH_Vol.29_Supplement2 page 47" href="http://viewer.zmags.com/publication/916a99fc?page=47"> ANNUAL MEETING ABSTRACTS 161 Loss of LINC004</a> <a title="MPATH_Vol.29_Supplement2 page 48" href="http://viewer.zmags.com/publication/916a99fc?page=48"> 44A preliminary investigation. Any nuclear staini</a> <a title="MPATH_Vol.29_Supplement2 page 49" href="http://viewer.zmags.com/publication/916a99fc?page=49"> ANNUAL MEETING ABSTRACTS 169 Correlation of </a> <a title="MPATH_Vol.29_Supplement2 page 50" href="http://viewer.zmags.com/publication/916a99fc?page=50"> 46A Design: We retrieved 210 TNBC mastectomy spec</a> <a title="MPATH_Vol.29_Supplement2 page 51" href="http://viewer.zmags.com/publication/916a99fc?page=51"> ANNUAL MEETING ABSTRACTS 178 The Role of a N</a> <a title="MPATH_Vol.29_Supplement2 page 52" href="http://viewer.zmags.com/publication/916a99fc?page=52"> 48A 182 RNA-Seq of Pleomorphic & Classic Lob</a> <a title="MPATH_Vol.29_Supplement2 page 53" href="http://viewer.zmags.com/publication/916a99fc?page=53"> ANNUAL MEETING ABSTRACTS aimed at studying the ex</a> <a title="MPATH_Vol.29_Supplement2 page 54" href="http://viewer.zmags.com/publication/916a99fc?page=54"> 50A between the two cohorts. The 5-year DFS proba</a> <a title="MPATH_Vol.29_Supplement2 page 55" href="http://viewer.zmags.com/publication/916a99fc?page=55"> ANNUAL MEETING ABSTRACTS 194 Negative Associ</a> <a title="MPATH_Vol.29_Supplement2 page 56" href="http://viewer.zmags.com/publication/916a99fc?page=56"> 52A the time of grossing. Cytology scrapings were</a> <a title="MPATH_Vol.29_Supplement2 page 57" href="http://viewer.zmags.com/publication/916a99fc?page=57"> ANNUAL MEETING ABSTRACTS of staining ranged from </a> <a title="MPATH_Vol.29_Supplement2 page 58" href="http://viewer.zmags.com/publication/916a99fc?page=58"> 54A metastases from the same patient showed a sim</a> <a title="MPATH_Vol.29_Supplement2 page 59" href="http://viewer.zmags.com/publication/916a99fc?page=59"> ANNUAL MEETING ABSTRACTS 212 RUNX3 Epigeneti</a> <a title="MPATH_Vol.29_Supplement2 page 60" href="http://viewer.zmags.com/publication/916a99fc?page=60"> 56A the neighborhood of each pixel for the remain</a> <a title="MPATH_Vol.29_Supplement2 page 61" href="http://viewer.zmags.com/publication/916a99fc?page=61"> ANNUAL MEETING ABSTRACTS 219 Intraoperative </a> <a title="MPATH_Vol.29_Supplement2 page 62" href="http://viewer.zmags.com/publication/916a99fc?page=62"> 58A pre-chemotherapy breast core biopsies. PDL-1 </a> <a title="MPATH_Vol.29_Supplement2 page 63" href="http://viewer.zmags.com/publication/916a99fc?page=63"> ANNUAL MEETING ABSTRACTS tumor (14 benign, 4 bord</a> <a title="MPATH_Vol.29_Supplement2 page 64" href="http://viewer.zmags.com/publication/916a99fc?page=64"> 60A ± trastuzumab and 4 cycles of anthracycline-b</a> <a title="MPATH_Vol.29_Supplement2 page 65" href="http://viewer.zmags.com/publication/916a99fc?page=65"> ANNUAL MEETING ABSTRACTS histology, histologic an</a> <a title="MPATH_Vol.29_Supplement2 page 66" href="http://viewer.zmags.com/publication/916a99fc?page=66"> 62A Hospital, developed equations using routinely</a> <a title="MPATH_Vol.29_Supplement2 page 67" href="http://viewer.zmags.com/publication/916a99fc?page=67"> ANNUAL MEETING ABSTRACTS determined using X-tile.</a> <a title="MPATH_Vol.29_Supplement2 page 68" href="http://viewer.zmags.com/publication/916a99fc?page=68"> 64A 247 Cytokeratin 7-Negative Mammary Paget</a> <a title="MPATH_Vol.29_Supplement2 page 69" href="http://viewer.zmags.com/publication/916a99fc?page=69"> ANNUAL MEETING ABSTRACTS OR* 95%CI OR**</a> <a title="MPATH_Vol.29_Supplement2 page 70" href="http://viewer.zmags.com/publication/916a99fc?page=70"> 66A Pure Metaplastic Carcinoma (n=6) Mixed Meta</a> <a title="MPATH_Vol.29_Supplement2 page 71" href="http://viewer.zmags.com/publication/916a99fc?page=71"> ANNUAL MEETING ABSTRACTS tumors can arise indepen</a> <a title="MPATH_Vol.29_Supplement2 page 72" href="http://viewer.zmags.com/publication/916a99fc?page=72"> 68A HER2+ (via FISH testing), 1.3% (1/80). 3 of t</a> <a title="MPATH_Vol.29_Supplement2 page 73" href="http://viewer.zmags.com/publication/916a99fc?page=73"> ANNUAL MEETING ABSTRACTS 268 TERT Hotspot Pr</a> <a title="MPATH_Vol.29_Supplement2 page 74" href="http://viewer.zmags.com/publication/916a99fc?page=74"> 70A including substitutions, insertions, deletion</a> <a title="MPATH_Vol.29_Supplement2 page 75" href="http://viewer.zmags.com/publication/916a99fc?page=75"> ANNUAL MEETING ABSTRACTS were available from 19 p</a> <a title="MPATH_Vol.29_Supplement2 page 76" href="http://viewer.zmags.com/publication/916a99fc?page=76"> 72A features, breast cancer specific survival app</a> <a title="MPATH_Vol.29_Supplement2 page 77" href="http://viewer.zmags.com/publication/916a99fc?page=77"> ANNUAL MEETING ABSTRACTS in the entire cohort or </a> <a title="MPATH_Vol.29_Supplement2 page 78" href="http://viewer.zmags.com/publication/916a99fc?page=78"> 74A 287 Analysis of Clinical-Pathological Da</a> <a title="MPATH_Vol.29_Supplement2 page 79" href="http://viewer.zmags.com/publication/916a99fc?page=79"> ANNUAL MEETING ABSTRACTS poor outcome in many tum</a> <a title="MPATH_Vol.29_Supplement2 page 80" href="http://viewer.zmags.com/publication/916a99fc?page=80"> 76A Results: 100% of cases that </a> <a title="MPATH_Vol.29_Supplement2 page 81" href="http://viewer.zmags.com/publication/916a99fc?page=81"> ANNUAL MEETING ABSTRACTS between RS and IHC3/IHC4</a> <a title="MPATH_Vol.29_Supplement2 page 82" href="http://viewer.zmags.com/publication/916a99fc?page=82"> 78A 303 TP53 Alteration in Morphologically N</a> <a title="MPATH_Vol.29_Supplement2 page 83" href="http://viewer.zmags.com/publication/916a99fc?page=83"> ANNUAL MEETING ABSTRACTS Breast AdCC Saliva</a> <a title="MPATH_Vol.29_Supplement2 page 84" href="http://viewer.zmags.com/publication/916a99fc?page=84"> 80A atypia underwent immediate excision: 5/9 (56%</a> <a title="MPATH_Vol.29_Supplement2 page 85" href="http://viewer.zmags.com/publication/916a99fc?page=85"> ANNUAL MEETING ABSTRACTS 315 Repair of the I</a> <a title="MPATH_Vol.29_Supplement2 page 86" href="http://viewer.zmags.com/publication/916a99fc?page=86"> 82A 7 pts had renal insufficiency. Of available c</a> <a title="MPATH_Vol.29_Supplement2 page 87" href="http://viewer.zmags.com/publication/916a99fc?page=87"> ANNUAL MEETING ABSTRACTS lesions with in-stent ru</a> <a title="MPATH_Vol.29_Supplement2 page 88" href="http://viewer.zmags.com/publication/916a99fc?page=88"> 84A 328 Sudden Cardiac Death in Young Athlet</a> <a title="MPATH_Vol.29_Supplement2 page 89" href="http://viewer.zmags.com/publication/916a99fc?page=89"> ANNUAL MEETING ABSTRACTS 333 Erosion Is More</a> <a title="MPATH_Vol.29_Supplement2 page 90" href="http://viewer.zmags.com/publication/916a99fc?page=90"> 86A 337 Left Ventricular Assist Device Can I</a> <a title="MPATH_Vol.29_Supplement2 page 91" href="http://viewer.zmags.com/publication/916a99fc?page=91"> ANNUAL MEETING ABSTRACTS specimens was only 33% (</a> <a title="MPATH_Vol.29_Supplement2 page 92" href="http://viewer.zmags.com/publication/916a99fc?page=92"> 88A Conclusions: The use </a> <a title="MPATH_Vol.29_Supplement2 page 93" href="http://viewer.zmags.com/publication/916a99fc?page=93"> ANNUAL MEETING ABSTRACTS be manifested as differe</a> <a title="MPATH_Vol.29_Supplement2 page 94" href="http://viewer.zmags.com/publication/916a99fc?page=94"> 90A 11/14 criteria were significantly associated </a> <a title="MPATH_Vol.29_Supplement2 page 95" href="http://viewer.zmags.com/publication/916a99fc?page=95"> ANNUAL MEETING ABSTRACTS Conclusions: UroVysion F</a> <a title="MPATH_Vol.29_Supplement2 page 96" href="http://viewer.zmags.com/publication/916a99fc?page=96"> 92A 359 Indeterminate Thyroid Nodules: Does </a> <a title="MPATH_Vol.29_Supplement2 page 97" href="http://viewer.zmags.com/publication/916a99fc?page=97"> ANNUAL MEETING ABSTRACTS Cytological Diagnosis, L</a> <a title="MPATH_Vol.29_Supplement2 page 98" href="http://viewer.zmags.com/publication/916a99fc?page=98"> 94A 366 Molecular Profiling of Malignant Pleu</a> <a title="MPATH_Vol.29_Supplement2 page 99" href="http://viewer.zmags.com/publication/916a99fc?page=99"> ANNUAL MEETING ABSTRACTS 369 Atypical Squamo</a> <a title="MPATH_Vol.29_Supplement2 page 100" href="http://viewer.zmags.com/publication/916a99fc?page=100"> 96A 373 CellDetect®, a Novel Urine-Based Bla</a> <a title="MPATH_Vol.29_Supplement2 page 101" href="http://viewer.zmags.com/publication/916a99fc?page=101"> ANNUAL MEETING ABSTRACTS in 41 cases and on fluid</a> <a title="MPATH_Vol.29_Supplement2 page 102" href="http://viewer.zmags.com/publication/916a99fc?page=102"> 98A GIST#(%) LM#(%) PNST#(%) ACA#(%</a> <a title="MPATH_Vol.29_Supplement2 page 103" href="http://viewer.zmags.com/publication/916a99fc?page=103"> ANNUAL MEETING ABSTRACTS 386 Utility of Next</a> <a title="MPATH_Vol.29_Supplement2 page 104" href="http://viewer.zmags.com/publication/916a99fc?page=104"> 100A 390 “Benign Endometrial Cells” Reportin</a> <a title="MPATH_Vol.29_Supplement2 page 105" href="http://viewer.zmags.com/publication/916a99fc?page=105"> ANNUAL MEETING ABSTRACTS First diagnosis Forced d</a> <a title="MPATH_Vol.29_Supplement2 page 106" href="http://viewer.zmags.com/publication/916a99fc?page=106"> 102A Cytology (PSRUC) Benign (n=45; 36%) AUC (n=3</a> <a title="MPATH_Vol.29_Supplement2 page 107" href="http://viewer.zmags.com/publication/916a99fc?page=107"> ANNUAL MEETING ABSTRACTS Design: Cases were revie</a> <a title="MPATH_Vol.29_Supplement2 page 108" href="http://viewer.zmags.com/publication/916a99fc?page=108"> 104A Metacyte slide scanning system. At least 25 </a> <a title="MPATH_Vol.29_Supplement2 page 109" href="http://viewer.zmags.com/publication/916a99fc?page=109"> ANNUAL MEETING ABSTRACTS mucinous neoplasm withou</a> <a title="MPATH_Vol.29_Supplement2 page 110" href="http://viewer.zmags.com/publication/916a99fc?page=110"> 106A The most common origins </a> <a title="MPATH_Vol.29_Supplement2 page 111" href="http://viewer.zmags.com/publication/916a99fc?page=111"> ANNUAL MEETING ABSTRACTS 416 Performance of </a> <a title="MPATH_Vol.29_Supplement2 page 112" href="http://viewer.zmags.com/publication/916a99fc?page=112"> 108A Cytology was evaluated for adequacy and clas</a> <a title="MPATH_Vol.29_Supplement2 page 113" href="http://viewer.zmags.com/publication/916a99fc?page=113"> ANNUAL MEETING ABSTRACTS major NGS platform manuf</a> <a title="MPATH_Vol.29_Supplement2 page 114" href="http://viewer.zmags.com/publication/916a99fc?page=114"> 110A Results: A total of 183 cases of salivary gl</a> <a title="MPATH_Vol.29_Supplement2 page 115" href="http://viewer.zmags.com/publication/916a99fc?page=115"> ANNUAL MEETING ABSTRACTS carcinoma (ACCi). We eva</a> <a title="MPATH_Vol.29_Supplement2 page 116" href="http://viewer.zmags.com/publication/916a99fc?page=116"> 112A 436 Diagnostic Accuracy and False Negat</a> <a title="MPATH_Vol.29_Supplement2 page 117" href="http://viewer.zmags.com/publication/916a99fc?page=117"> ANNUAL MEETING ABSTRACTS 440 An Emerging Rol</a> <a title="MPATH_Vol.29_Supplement2 page 118" href="http://viewer.zmags.com/publication/916a99fc?page=118"> 114A Results: 27 unique patients had two serial L</a> <a title="MPATH_Vol.29_Supplement2 page 119" href="http://viewer.zmags.com/publication/916a99fc?page=119"> ANNUAL MEETING ABSTRACTS and 8 cases, respectivel</a> <a title="MPATH_Vol.29_Supplement2 page 120" href="http://viewer.zmags.com/publication/916a99fc?page=120"> 116A 451 Accuracy of Intraoperative Imprint </a> <a title="MPATH_Vol.29_Supplement2 page 121" href="http://viewer.zmags.com/publication/916a99fc?page=121"> ANNUAL MEETING ABSTRACTS Conclusions: 1. OhrHPVs </a> <a title="MPATH_Vol.29_Supplement2 page 122" href="http://viewer.zmags.com/publication/916a99fc?page=122"> 118A Conclusions: The preliminary results indicat</a> <a title="MPATH_Vol.29_Supplement2 page 123" href="http://viewer.zmags.com/publication/916a99fc?page=123"> ANNUAL MEETING ABSTRACTS 463 Endometrial Cel</a> <a title="MPATH_Vol.29_Supplement2 page 124" href="http://viewer.zmags.com/publication/916a99fc?page=124"> 120A 466 On-Site Adequacy Evaluation Does No</a> <a title="MPATH_Vol.29_Supplement2 page 125" href="http://viewer.zmags.com/publication/916a99fc?page=125"> ANNUAL MEETING ABSTRACTS proliferation rate was c</a> <a title="MPATH_Vol.29_Supplement2 page 126" href="http://viewer.zmags.com/publication/916a99fc?page=126"> 122A by adapting Mathur’s criteria (SURGERY 156:1</a> <a title="MPATH_Vol.29_Supplement2 page 127" href="http://viewer.zmags.com/publication/916a99fc?page=127"> ANNUAL MEETING ABSTRACTS relatively new technique</a> <a title="MPATH_Vol.29_Supplement2 page 128" href="http://viewer.zmags.com/publication/916a99fc?page=128"> 124A associated with EGFR mutation as a result of</a> <a title="MPATH_Vol.29_Supplement2 page 129" href="http://viewer.zmags.com/publication/916a99fc?page=129"> ANNUAL MEETING ABSTRACTS liver (3), abdominal wal</a> <a title="MPATH_Vol.29_Supplement2 page 130" href="http://viewer.zmags.com/publication/916a99fc?page=130"> 126A particular, invasion beyond the skin and met</a> <a title="MPATH_Vol.29_Supplement2 page 131" href="http://viewer.zmags.com/publication/916a99fc?page=131"> ANNUAL MEETING ABSTRACTS and real–time PCR. The t</a> <a title="MPATH_Vol.29_Supplement2 page 132" href="http://viewer.zmags.com/publication/916a99fc?page=132"> 128A dermatofibroma, lichen simplex, and Kaposi s</a> <a title="MPATH_Vol.29_Supplement2 page 133" href="http://viewer.zmags.com/publication/916a99fc?page=133"> ANNUAL MEETING ABSTRACTS Design: The eight probes</a> <a title="MPATH_Vol.29_Supplement2 page 134" href="http://viewer.zmags.com/publication/916a99fc?page=134"> 130A Results: HRAS c.37G>C mutation was detected </a> <a title="MPATH_Vol.29_Supplement2 page 135" href="http://viewer.zmags.com/publication/916a99fc?page=135"> ANNUAL MEETING ABSTRACTS Negative Predictive Valu</a> <a title="MPATH_Vol.29_Supplement2 page 136" href="http://viewer.zmags.com/publication/916a99fc?page=136"> 132A of 16 patients (range 4 to 72 months, mean 2</a> <a title="MPATH_Vol.29_Supplement2 page 137" href="http://viewer.zmags.com/publication/916a99fc?page=137"> ANNUAL MEETING ABSTRACTS 517 Differential NF</a> <a title="MPATH_Vol.29_Supplement2 page 138" href="http://viewer.zmags.com/publication/916a99fc?page=138"> 134A in MF patients with plaque stage skin diseas</a> <a title="MPATH_Vol.29_Supplement2 page 139" href="http://viewer.zmags.com/publication/916a99fc?page=139"> ANNUAL MEETING ABSTRACTS 526 Relationship be</a> <a title="MPATH_Vol.29_Supplement2 page 140" href="http://viewer.zmags.com/publication/916a99fc?page=140"> 136A 530 Clinical Significance of BRAF V600E </a> <a title="MPATH_Vol.29_Supplement2 page 141" href="http://viewer.zmags.com/publication/916a99fc?page=141"> ANNUAL MEETING ABSTRACTS 534 Whole Exome Seq</a> <a title="MPATH_Vol.29_Supplement2 page 142" href="http://viewer.zmags.com/publication/916a99fc?page=142"> 138A 538 Clinicopathologic Characterization </a> <a title="MPATH_Vol.29_Supplement2 page 143" href="http://viewer.zmags.com/publication/916a99fc?page=143"> ANNUAL MEETING ABSTRACTS oncogenic, signaling pro</a> <a title="MPATH_Vol.29_Supplement2 page 144" href="http://viewer.zmags.com/publication/916a99fc?page=144"> 140A 546 Development of an Online Case Simul</a> <a title="MPATH_Vol.29_Supplement2 page 145" href="http://viewer.zmags.com/publication/916a99fc?page=145"> ANNUAL MEETING ABSTRACTS transition to the attend</a> <a title="MPATH_Vol.29_Supplement2 page 146" href="http://viewer.zmags.com/publication/916a99fc?page=146"> 142A standardized. We propose a system to enhance</a> <a title="MPATH_Vol.29_Supplement2 page 147" href="http://viewer.zmags.com/publication/916a99fc?page=147"> ANNUAL MEETING ABSTRACTS 90% and 95%, respectivel</a> <a title="MPATH_Vol.29_Supplement2 page 148" href="http://viewer.zmags.com/publication/916a99fc?page=148"> 144A Design: Four surgical pathologists and a chi</a> <a title="MPATH_Vol.29_Supplement2 page 149" href="http://viewer.zmags.com/publication/916a99fc?page=149"> ANNUAL MEETING ABSTRACTS 565 Four Years of V</a> <a title="MPATH_Vol.29_Supplement2 page 150" href="http://viewer.zmags.com/publication/916a99fc?page=150"> 146A Conclusions: Routine SSTR2A in NENs is clini</a> <a title="MPATH_Vol.29_Supplement2 page 151" href="http://viewer.zmags.com/publication/916a99fc?page=151"> ANNUAL MEETING ABSTRACTS Table 1. Sensitivity, Sp</a> <a title="MPATH_Vol.29_Supplement2 page 152" href="http://viewer.zmags.com/publication/916a99fc?page=152"> 148A Conclusions: Our results suggest that RI ref</a> <a title="MPATH_Vol.29_Supplement2 page 153" href="http://viewer.zmags.com/publication/916a99fc?page=153"> ANNUAL MEETING ABSTRACTS ATRX w</a> <a title="MPATH_Vol.29_Supplement2 page 154" href="http://viewer.zmags.com/publication/916a99fc?page=154"> 150A Conclusions: In our series, PCT with positiv</a> <a title="MPATH_Vol.29_Supplement2 page 155" href="http://viewer.zmags.com/publication/916a99fc?page=155"> ANNUAL MEETING ABSTRACTS not use it. Despite this</a> <a title="MPATH_Vol.29_Supplement2 page 156" href="http://viewer.zmags.com/publication/916a99fc?page=156"> 152A MTCs were classified according to WHO into v</a> <a title="MPATH_Vol.29_Supplement2 page 157" href="http://viewer.zmags.com/publication/916a99fc?page=157"> ANNUAL MEETING ABSTRACTS Of the 14 FTA/FTCs with </a> <a title="MPATH_Vol.29_Supplement2 page 158" href="http://viewer.zmags.com/publication/916a99fc?page=158"> 154A Results: GATA3 was negative in 90% of ACC, w</a> <a title="MPATH_Vol.29_Supplement2 page 159" href="http://viewer.zmags.com/publication/916a99fc?page=159"> ANNUAL MEETING ABSTRACTS 605 Sclerosing Muco</a> <a title="MPATH_Vol.29_Supplement2 page 160" href="http://viewer.zmags.com/publication/916a99fc?page=160"> 156A Conclusions: TGDC carcinomas are uncommon, w</a> <a title="MPATH_Vol.29_Supplement2 page 161" href="http://viewer.zmags.com/publication/916a99fc?page=161"> ANNUAL MEETING ABSTRACTS gene-expression classifi</a> <a title="MPATH_Vol.29_Supplement2 page 162" href="http://viewer.zmags.com/publication/916a99fc?page=162"> 158A Conclusions: Our data point to GLUT1 as a po</a> <a title="MPATH_Vol.29_Supplement2 page 163" href="http://viewer.zmags.com/publication/916a99fc?page=163"> ANNUAL MEETING ABSTRACTS stained sections were in</a> <a title="MPATH_Vol.29_Supplement2 page 164" href="http://viewer.zmags.com/publication/916a99fc?page=164"> 160A bed sections and a minimum of 1 section per </a> <a title="MPATH_Vol.29_Supplement2 page 165" href="http://viewer.zmags.com/publication/916a99fc?page=165"> ANNUAL MEETING ABSTRACTS Design: A total of 171 c</a> <a title="MPATH_Vol.29_Supplement2 page 166" href="http://viewer.zmags.com/publication/916a99fc?page=166"> 162A 635 The Impact of Deeper Levels on the </a> <a title="MPATH_Vol.29_Supplement2 page 167" href="http://viewer.zmags.com/publication/916a99fc?page=167"> ANNUAL MEETING ABSTRACTS miRNA Appendix WDNET</a> <a title="MPATH_Vol.29_Supplement2 page 168" href="http://viewer.zmags.com/publication/916a99fc?page=168"> 164A the idea that colorectal cancer patients wit</a> <a title="MPATH_Vol.29_Supplement2 page 169" href="http://viewer.zmags.com/publication/916a99fc?page=169"> ANNUAL MEETING ABSTRACTS for our study. In this s</a> <a title="MPATH_Vol.29_Supplement2 page 170" href="http://viewer.zmags.com/publication/916a99fc?page=170"> 166A Institute, 1994). Unresectability and recurr</a> <a title="MPATH_Vol.29_Supplement2 page 171" href="http://viewer.zmags.com/publication/916a99fc?page=171"> ANNUAL MEETING ABSTRACTS Table 1. Genta necessity</a> <a title="MPATH_Vol.29_Supplement2 page 172" href="http://viewer.zmags.com/publication/916a99fc?page=172"> 168A p=0.03) and H. pylori infection (mean: 48, p</a> <a title="MPATH_Vol.29_Supplement2 page 173" href="http://viewer.zmags.com/publication/916a99fc?page=173"> ANNUAL MEETING ABSTRACTS optimal management of th</a> <a title="MPATH_Vol.29_Supplement2 page 174" href="http://viewer.zmags.com/publication/916a99fc?page=174"> 170A cells. In comparison, PDGC cases had an aver</a> <a title="MPATH_Vol.29_Supplement2 page 175" href="http://viewer.zmags.com/publication/916a99fc?page=175"> ANNUAL MEETING ABSTRACTS wt-BRAF with MLH1 promot</a> <a title="MPATH_Vol.29_Supplement2 page 176" href="http://viewer.zmags.com/publication/916a99fc?page=176"> 172A (MSS WD) CRC (n=30), and poorly differentiat</a> <a title="MPATH_Vol.29_Supplement2 page 177" href="http://viewer.zmags.com/publication/916a99fc?page=177"> ANNUAL MEETING ABSTRACTS tumor size and lack of e</a> <a title="MPATH_Vol.29_Supplement2 page 178" href="http://viewer.zmags.com/publication/916a99fc?page=178"> 174A Conclusions: T. pallidum IHC is 100% sensiti</a> <a title="MPATH_Vol.29_Supplement2 page 179" href="http://viewer.zmags.com/publication/916a99fc?page=179"> ANNUAL MEETING ABSTRACTS </a> <a title="MPATH_Vol.29_Supplement2 page 180" href="http://viewer.zmags.com/publication/916a99fc?page=180"> 176A surveillance endoscopy for symptoms of epiga</a> <a title="MPATH_Vol.29_Supplement2 page 181" href="http://viewer.zmags.com/publication/916a99fc?page=181"> ANNUAL MEETING ABSTRACTS occlude vessels and emit</a> <a title="MPATH_Vol.29_Supplement2 page 182" href="http://viewer.zmags.com/publication/916a99fc?page=182"> 178A negative for mutation KRAS mutation on exo</a> <a title="MPATH_Vol.29_Supplement2 page 183" href="http://viewer.zmags.com/publication/916a99fc?page=183"> ANNUAL MEETING ABSTRACTS Conclusions: SPNs show c</a> <a title="MPATH_Vol.29_Supplement2 page 184" href="http://viewer.zmags.com/publication/916a99fc?page=184"> 180A via the Illumina HiSeq 2500 system. The data</a> <a title="MPATH_Vol.29_Supplement2 page 185" href="http://viewer.zmags.com/publication/916a99fc?page=185"> ANNUAL MEETING ABSTRACTS Conclusions: Sporadic (t</a> <a title="MPATH_Vol.29_Supplement2 page 186" href="http://viewer.zmags.com/publication/916a99fc?page=186"> 182A 719 Diagnosing Colorectal Medullary Car</a> <a title="MPATH_Vol.29_Supplement2 page 187" href="http://viewer.zmags.com/publication/916a99fc?page=187"> ANNUAL MEETING ABSTRACTS Results: In the new case</a> <a title="MPATH_Vol.29_Supplement2 page 188" href="http://viewer.zmags.com/publication/916a99fc?page=188"> 184A 728 A Prospective Evaluation of Inciden</a> <a title="MPATH_Vol.29_Supplement2 page 189" href="http://viewer.zmags.com/publication/916a99fc?page=189"> ANNUAL MEETING ABSTRACTS to determine Fleiss’ kap</a> <a title="MPATH_Vol.29_Supplement2 page 190" href="http://viewer.zmags.com/publication/916a99fc?page=190"> 186A exact mechanism of combination and pathogene</a> <a title="MPATH_Vol.29_Supplement2 page 191" href="http://viewer.zmags.com/publication/916a99fc?page=191"> ANNUAL MEETING ABSTRACTS is particularly the case</a> <a title="MPATH_Vol.29_Supplement2 page 192" href="http://viewer.zmags.com/publication/916a99fc?page=192"> 188A of CD after 20 years of follow-up, and four </a> <a title="MPATH_Vol.29_Supplement2 page 193" href="http://viewer.zmags.com/publication/916a99fc?page=193"> ANNUAL MEETING ABSTRACTS 750 The Prognostic </a> <a title="MPATH_Vol.29_Supplement2 page 194" href="http://viewer.zmags.com/publication/916a99fc?page=194"> 190A 754 CD44 Expression and Its Clinical an</a> <a title="MPATH_Vol.29_Supplement2 page 195" href="http://viewer.zmags.com/publication/916a99fc?page=195"> ANNUAL MEETING ABSTRACTS CRC is unclear. Our goal</a> <a title="MPATH_Vol.29_Supplement2 page 196" href="http://viewer.zmags.com/publication/916a99fc?page=196"> 192A Results: Cases included conventional endomet</a> <a title="MPATH_Vol.29_Supplement2 page 197" href="http://viewer.zmags.com/publication/916a99fc?page=197"> ANNUAL MEETING ABSTRACTS a paucity of duodenal/bu</a> <a title="MPATH_Vol.29_Supplement2 page 198" href="http://viewer.zmags.com/publication/916a99fc?page=198"> 194A Polyp Type (C) Neg (C) Low (C) H</a> <a title="MPATH_Vol.29_Supplement2 page 199" href="http://viewer.zmags.com/publication/916a99fc?page=199"> ANNUAL MEETING ABSTRACTS Results: All 30 CRCs sho</a> <a title="MPATH_Vol.29_Supplement2 page 200" href="http://viewer.zmags.com/publication/916a99fc?page=200"> 196A Conclusions</a> <a title="MPATH_Vol.29_Supplement2 page 201" href="http://viewer.zmags.com/publication/916a99fc?page=201"> ANNUAL MEETING ABSTRACTS On the othe</a> <a title="MPATH_Vol.29_Supplement2 page 202" href="http://viewer.zmags.com/publication/916a99fc?page=202"> 198A MLH1/PMS2 loss with corresponding MLH1 germl</a> <a title="MPATH_Vol.29_Supplement2 page 203" href="http://viewer.zmags.com/publication/916a99fc?page=203"> ANNUAL MEETING ABSTRACTS using Lipofectamine 2000</a> <a title="MPATH_Vol.29_Supplement2 page 204" href="http://viewer.zmags.com/publication/916a99fc?page=204"> 200A Carcinoma with lymphoid stroma phenotype is </a> <a title="MPATH_Vol.29_Supplement2 page 205" href="http://viewer.zmags.com/publication/916a99fc?page=205"> ANNUAL MEETING ABSTRACTS Results: Of the 45 cases</a> <a title="MPATH_Vol.29_Supplement2 page 206" href="http://viewer.zmags.com/publication/916a99fc?page=206"> 202A 800 Comparative Study of Genome-Wide Co</a> <a title="MPATH_Vol.29_Supplement2 page 207" href="http://viewer.zmags.com/publication/916a99fc?page=207"> ANNUAL MEETING ABSTRACTS has more than 20 times a</a> <a title="MPATH_Vol.29_Supplement2 page 208" href="http://viewer.zmags.com/publication/916a99fc?page=208"> 204A Design: Following a previous validation stud</a> <a title="MPATH_Vol.29_Supplement2 page 209" href="http://viewer.zmags.com/publication/916a99fc?page=209"> ANNUAL MEETING ABSTRACTS Study 3-tier grading</a> <a title="MPATH_Vol.29_Supplement2 page 210" href="http://viewer.zmags.com/publication/916a99fc?page=210"> 206A known as the origin of certain types of mull</a> <a title="MPATH_Vol.29_Supplement2 page 211" href="http://viewer.zmags.com/publication/916a99fc?page=211"> ANNUAL MEETING ABSTRACTS Six patients (22%) prese</a> <a title="MPATH_Vol.29_Supplement2 page 212" href="http://viewer.zmags.com/publication/916a99fc?page=212"> 208A Conclusions: This study identified that AA p</a> <a title="MPATH_Vol.29_Supplement2 page 213" href="http://viewer.zmags.com/publication/916a99fc?page=213"> ANNUAL MEETING ABSTRACTS 827 Colorectal Aden</a> <a title="MPATH_Vol.29_Supplement2 page 214" href="http://viewer.zmags.com/publication/916a99fc?page=214"> 210A reactivity was defined as chromogen visualiz</a> <a title="MPATH_Vol.29_Supplement2 page 215" href="http://viewer.zmags.com/publication/916a99fc?page=215"> ANNUAL MEETING ABSTRACTS CS. 6 CS patients were t</a> <a title="MPATH_Vol.29_Supplement2 page 216" href="http://viewer.zmags.com/publication/916a99fc?page=216"> 212A 840 Post-Appendectomy Colorectal Adenoc</a> <a title="MPATH_Vol.29_Supplement2 page 217" href="http://viewer.zmags.com/publication/916a99fc?page=217"> ANNUAL MEETING ABSTRACTS 844 Is Mast Cell In</a> <a title="MPATH_Vol.29_Supplement2 page 218" href="http://viewer.zmags.com/publication/916a99fc?page=218"> 214A and PTEN (3%), some of which were not detect</a> <a title="MPATH_Vol.29_Supplement2 page 219" href="http://viewer.zmags.com/publication/916a99fc?page=219"> ANNUAL MEETING ABSTRACTS A previ</a> <a title="MPATH_Vol.29_Supplement2 page 220" href="http://viewer.zmags.com/publication/916a99fc?page=220"> 216A nodules has no added value. In multifocal tu</a> <a title="MPATH_Vol.29_Supplement2 page 221" href="http://viewer.zmags.com/publication/916a99fc?page=221"> ANNUAL MEETING ABSTRACTS Results: Of the total 82</a> <a title="MPATH_Vol.29_Supplement2 page 222" href="http://viewer.zmags.com/publication/916a99fc?page=222"> 218A suppressor, is known to occur in aggressive </a> <a title="MPATH_Vol.29_Supplement2 page 223" href="http://viewer.zmags.com/publication/916a99fc?page=223"> ANNUAL MEETING ABSTRACTS varied among GP4 morphol</a> <a title="MPATH_Vol.29_Supplement2 page 224" href="http://viewer.zmags.com/publication/916a99fc?page=224"> 220A 873 Distinct Clinicopathological Featur</a> <a title="MPATH_Vol.29_Supplement2 page 225" href="http://viewer.zmags.com/publication/916a99fc?page=225"> ANNUAL MEETING ABSTRACTS analyzed to determine th</a> <a title="MPATH_Vol.29_Supplement2 page 226" href="http://viewer.zmags.com/publication/916a99fc?page=226"> 222A IDC, extraprostatic extension (EPE), seminal</a> <a title="MPATH_Vol.29_Supplement2 page 227" href="http://viewer.zmags.com/publication/916a99fc?page=227"> ANNUAL MEETING ABSTRACTS </a> <a title="MPATH_Vol.29_Supplement2 page 228" href="http://viewer.zmags.com/publication/916a99fc?page=228"> 224A 888 Human Hemochromatosis Protein (HFE)</a> <a title="MPATH_Vol.29_Supplement2 page 229" href="http://viewer.zmags.com/publication/916a99fc?page=229"> ANNUAL MEETING ABSTRACTS regression models were u</a> <a title="MPATH_Vol.29_Supplement2 page 230" href="http://viewer.zmags.com/publication/916a99fc?page=230"> 226A biopsy with limited success. Currently, all </a> <a title="MPATH_Vol.29_Supplement2 page 231" href="http://viewer.zmags.com/publication/916a99fc?page=231"> ANNUAL MEETING ABSTRACTS Results: Among these 19 </a> <a title="MPATH_Vol.29_Supplement2 page 232" href="http://viewer.zmags.com/publication/916a99fc?page=232"> 228A 905 Clinicopathologic Features and Outc</a> <a title="MPATH_Vol.29_Supplement2 page 233" href="http://viewer.zmags.com/publication/916a99fc?page=233"> ANNUAL MEETING ABSTRACTS Design: 324 prostatectom</a> <a title="MPATH_Vol.29_Supplement2 page 234" href="http://viewer.zmags.com/publication/916a99fc?page=234"> 230A paired core biopsy/nephrectomy cases. Additi</a> <a title="MPATH_Vol.29_Supplement2 page 235" href="http://viewer.zmags.com/publication/916a99fc?page=235"> ANNUAL MEETING ABSTRACTS 917 The Spectrum of</a> <a title="MPATH_Vol.29_Supplement2 page 236" href="http://viewer.zmags.com/publication/916a99fc?page=236"> 232A Results: A wide morphologic spectrum of epit</a> <a title="MPATH_Vol.29_Supplement2 page 237" href="http://viewer.zmags.com/publication/916a99fc?page=237"> ANNUAL MEETING ABSTRACTS Conclusions: Patients fr</a> <a title="MPATH_Vol.29_Supplement2 page 238" href="http://viewer.zmags.com/publication/916a99fc?page=238"> 234A Conclusions: Our preliminary findings sugges</a> <a title="MPATH_Vol.29_Supplement2 page 239" href="http://viewer.zmags.com/publication/916a99fc?page=239"> ANNUAL MEETING ABSTRACTS PNL2 (%) HMB45 (%)</a> <a title="MPATH_Vol.29_Supplement2 page 240" href="http://viewer.zmags.com/publication/916a99fc?page=240"> 236A Conclusions: Our study indicates SDH mutatio</a> <a title="MPATH_Vol.29_Supplement2 page 241" href="http://viewer.zmags.com/publication/916a99fc?page=241"> ANNUAL MEETING ABSTRACTS 941 Discrepancy Bet</a> <a title="MPATH_Vol.29_Supplement2 page 242" href="http://viewer.zmags.com/publication/916a99fc?page=242"> 238A 945 Genitourinary Rhabdomyosarcoma – A </a> <a title="MPATH_Vol.29_Supplement2 page 243" href="http://viewer.zmags.com/publication/916a99fc?page=243"> ANNUAL MEETING ABSTRACTS 949 Atypical Cribri</a> <a title="MPATH_Vol.29_Supplement2 page 244" href="http://viewer.zmags.com/publication/916a99fc?page=244"> 240A Table 1: Correlation between PTEN expression</a> <a title="MPATH_Vol.29_Supplement2 page 245" href="http://viewer.zmags.com/publication/916a99fc?page=245"> ANNUAL MEETING ABSTRACTS 957 Interobserver A</a> <a title="MPATH_Vol.29_Supplement2 page 246" href="http://viewer.zmags.com/publication/916a99fc?page=246"> 242A were immunoreactive for EP3 (P=0.002). Howev</a> <a title="MPATH_Vol.29_Supplement2 page 247" href="http://viewer.zmags.com/publication/916a99fc?page=247"> ANNUAL MEETING ABSTRACTS 966 Renal Tumors wi</a> <a title="MPATH_Vol.29_Supplement2 page 248" href="http://viewer.zmags.com/publication/916a99fc?page=248"> 244A PTEN loss on GS6 needle biopsies has been sh</a> <a title="MPATH_Vol.29_Supplement2 page 249" href="http://viewer.zmags.com/publication/916a99fc?page=249"> ANNUAL MEETING ABSTRACTS Table 1. GR Expression i</a> <a title="MPATH_Vol.29_Supplement2 page 250" href="http://viewer.zmags.com/publication/916a99fc?page=250"> 246A 979 Quantifying Gleason Pattern 4 Prost</a> <a title="MPATH_Vol.29_Supplement2 page 251" href="http://viewer.zmags.com/publication/916a99fc?page=251"> ANNUAL MEETING ABSTRACTS Scientific, Waltham, MA)</a> <a title="MPATH_Vol.29_Supplement2 page 252" href="http://viewer.zmags.com/publication/916a99fc?page=252"> 248A various morphologies of UC. The relationship</a> <a title="MPATH_Vol.29_Supplement2 page 253" href="http://viewer.zmags.com/publication/916a99fc?page=253"> ANNUAL MEETING ABSTRACTS 991 Lymphovascular </a> <a title="MPATH_Vol.29_Supplement2 page 254" href="http://viewer.zmags.com/publication/916a99fc?page=254"> 250A Design: Retrospective clinicopathologic anal</a> <a title="MPATH_Vol.29_Supplement2 page 255" href="http://viewer.zmags.com/publication/916a99fc?page=255"> ANNUAL MEETING ABSTRACTS the expression of miRNAs</a> <a title="MPATH_Vol.29_Supplement2 page 256" href="http://viewer.zmags.com/publication/916a99fc?page=256"> 252A 1003 Natural History of Human Papillomavi</a> <a title="MPATH_Vol.29_Supplement2 page 257" href="http://viewer.zmags.com/publication/916a99fc?page=257"> ANNUAL MEETING ABSTRACTS 1007 MuscularisMucosa</a> <a title="MPATH_Vol.29_Supplement2 page 258" href="http://viewer.zmags.com/publication/916a99fc?page=258"> 254A Results: Patients were 8 males, 4 females wi</a> <a title="MPATH_Vol.29_Supplement2 page 259" href="http://viewer.zmags.com/publication/916a99fc?page=259"> ANNUAL MEETING ABSTRACTS 1014 FOXA1: A Transcr</a> <a title="MPATH_Vol.29_Supplement2 page 260" href="http://viewer.zmags.com/publication/916a99fc?page=260"> 256A 1018 Utility</a> <a title="MPATH_Vol.29_Supplement2 page 261" href="http://viewer.zmags.com/publication/916a99fc?page=261"> ANNUAL MEETING ABSTRACTS Table: Paratesticular so</a> <a title="MPATH_Vol.29_Supplement2 page 262" href="http://viewer.zmags.com/publication/916a99fc?page=262"> 258A Conclusions: 1)There is a</a> <a title="MPATH_Vol.29_Supplement2 page 263" href="http://viewer.zmags.com/publication/916a99fc?page=263"> ANNUAL MEETING ABSTRACTS Design: 14 cases of HGRC</a> <a title="MPATH_Vol.29_Supplement2 page 264" href="http://viewer.zmags.com/publication/916a99fc?page=264"> 260A 1032 Metabolomics Analysis Reveals Distin</a> <a title="MPATH_Vol.29_Supplement2 page 265" href="http://viewer.zmags.com/publication/916a99fc?page=265"> ANNUAL MEETING ABSTRACTS Design: Immunohistochemi</a> <a title="MPATH_Vol.29_Supplement2 page 266" href="http://viewer.zmags.com/publication/916a99fc?page=266"> 262A Results: 2471 PNBs were performed during the</a> <a title="MPATH_Vol.29_Supplement2 page 267" href="http://viewer.zmags.com/publication/916a99fc?page=267"> ANNUAL MEETING ABSTRACTS Conclusions: Sarcomatoid</a> <a title="MPATH_Vol.29_Supplement2 page 268" href="http://viewer.zmags.com/publication/916a99fc?page=268"> 264A morphology, cytoplasmic flocculence/vacuolat</a> <a title="MPATH_Vol.29_Supplement2 page 269" href="http://viewer.zmags.com/publication/916a99fc?page=269"> ANNUAL MEETING ABSTRACTS We further</a> <a title="MPATH_Vol.29_Supplement2 page 270" href="http://viewer.zmags.com/publication/916a99fc?page=270"> 266A (Leica Biosystems) and visually evaluated be</a> <a title="MPATH_Vol.29_Supplement2 page 271" href="http://viewer.zmags.com/publication/916a99fc?page=271"> ANNUAL MEETING ABSTRACTS Results: 29 cases using </a> <a title="MPATH_Vol.29_Supplement2 page 272" href="http://viewer.zmags.com/publication/916a99fc?page=272"> 268A pT3), 1973 WHO grade (G2 or G3), and lymph n</a> <a title="MPATH_Vol.29_Supplement2 page 273" href="http://viewer.zmags.com/publication/916a99fc?page=273"> ANNUAL MEETING ABSTRACTS 1068 Better Treatment</a> <a title="MPATH_Vol.29_Supplement2 page 274" href="http://viewer.zmags.com/publication/916a99fc?page=274"> 270A TE PN p-value average margin dista</a> <a title="MPATH_Vol.29_Supplement2 page 275" href="http://viewer.zmags.com/publication/916a99fc?page=275"> ANNUAL MEETING ABSTRACTS </a> <a title="MPATH_Vol.29_Supplement2 page 276" href="http://viewer.zmags.com/publication/916a99fc?page=276"> 272A Design: Tissue microarrays (TMAs) were const</a> <a title="MPATH_Vol.29_Supplement2 page 277" href="http://viewer.zmags.com/publication/916a99fc?page=277"> ANNUAL MEETING ABSTRACTS undifferentiated(5) and </a> <a title="MPATH_Vol.29_Supplement2 page 278" href="http://viewer.zmags.com/publication/916a99fc?page=278"> 274A 1088 Rare Subtype(s) and Frequency of Mul</a> <a title="MPATH_Vol.29_Supplement2 page 279" href="http://viewer.zmags.com/publication/916a99fc?page=279"> ANNUAL MEETING ABSTRACTS becomes standard practic</a> <a title="MPATH_Vol.29_Supplement2 page 280" href="http://viewer.zmags.com/publication/916a99fc?page=280"> 276A protein 78 (GRP78), an endoplasmic reticular</a> <a title="MPATH_Vol.29_Supplement2 page 281" href="http://viewer.zmags.com/publication/916a99fc?page=281"> ANNUAL MEETING ABSTRACTS associated paclitaxel re</a> <a title="MPATH_Vol.29_Supplement2 page 282" href="http://viewer.zmags.com/publication/916a99fc?page=282"> 278A Design: Patients eligible for the protocol h</a> <a title="MPATH_Vol.29_Supplement2 page 283" href="http://viewer.zmags.com/publication/916a99fc?page=283"> ANNUAL MEETING ABSTRACTS PAX-8 immunoexpression w</a> <a title="MPATH_Vol.29_Supplement2 page 284" href="http://viewer.zmags.com/publication/916a99fc?page=284"> 280A N (%) Age <40 years 25(78%) >=40 yea</a> <a title="MPATH_Vol.29_Supplement2 page 285" href="http://viewer.zmags.com/publication/916a99fc?page=285"> ANNUAL MEETING ABSTRACTS distinguished from true </a> <a title="MPATH_Vol.29_Supplement2 page 286" href="http://viewer.zmags.com/publication/916a99fc?page=286"> 282A addition, BE can be architecturally complex </a> <a title="MPATH_Vol.29_Supplement2 page 287" href="http://viewer.zmags.com/publication/916a99fc?page=287"> ANNUAL MEETING ABSTRACTS incomplete lymphadenecto</a> <a title="MPATH_Vol.29_Supplement2 page 288" href="http://viewer.zmags.com/publication/916a99fc?page=288"> 284A hyperplasia was observed in all cases. The c</a> <a title="MPATH_Vol.29_Supplement2 page 289" href="http://viewer.zmags.com/publication/916a99fc?page=289"> ANNUAL MEETING ABSTRACTS prognostic information b</a> <a title="MPATH_Vol.29_Supplement2 page 290" href="http://viewer.zmags.com/publication/916a99fc?page=290"> 286A 1137 Rethinking Decidual Vasculopathy of </a> <a title="MPATH_Vol.29_Supplement2 page 291" href="http://viewer.zmags.com/publication/916a99fc?page=291"> ANNUAL MEETING ABSTRACTS Conclusions: Molecular c</a> <a title="MPATH_Vol.29_Supplement2 page 292" href="http://viewer.zmags.com/publication/916a99fc?page=292"> 288A amplification and 4/23 (17%) had co-gain of </a> <a title="MPATH_Vol.29_Supplement2 page 293" href="http://viewer.zmags.com/publication/916a99fc?page=293"> ANNUAL MEETING ABSTRACTS 2 were 3 and 24/10 HPF, </a> <a title="MPATH_Vol.29_Supplement2 page 294" href="http://viewer.zmags.com/publication/916a99fc?page=294"> 290A with cornual resection, even though the extr</a> <a title="MPATH_Vol.29_Supplement2 page 295" href="http://viewer.zmags.com/publication/916a99fc?page=295"> ANNUAL MEETING ABSTRACTS 1156 Adenosquamous Ca</a> <a title="MPATH_Vol.29_Supplement2 page 296" href="http://viewer.zmags.com/publication/916a99fc?page=296"> 292A 1160 Whole Exon Sequencing of Malignant B</a> <a title="MPATH_Vol.29_Supplement2 page 297" href="http://viewer.zmags.com/publication/916a99fc?page=297"> ANNUAL MEETING ABSTRACTS 6.14 vs 11.31 years, p=0</a> <a title="MPATH_Vol.29_Supplement2 page 298" href="http://viewer.zmags.com/publication/916a99fc?page=298"> 294A 1168 Genomewide Copy Number Analysis of M</a> <a title="MPATH_Vol.29_Supplement2 page 299" href="http://viewer.zmags.com/publication/916a99fc?page=299"> ANNUAL MEETING ABSTRACTS Conc</a> <a title="MPATH_Vol.29_Supplement2 page 300" href="http://viewer.zmags.com/publication/916a99fc?page=300"> 296A Design: We identified six cases of previousl</a> <a title="MPATH_Vol.29_Supplement2 page 301" href="http://viewer.zmags.com/publication/916a99fc?page=301"> ANNUAL MEETING ABSTRACTS were geographically rest</a> <a title="MPATH_Vol.29_Supplement2 page 302" href="http://viewer.zmags.com/publication/916a99fc?page=302"> 298A atypia, cellularity, mitotic index, type of </a> <a title="MPATH_Vol.29_Supplement2 page 303" href="http://viewer.zmags.com/publication/916a99fc?page=303"> ANNUAL MEETING ABSTRACTS 1187 Utility of Uropl</a> <a title="MPATH_Vol.29_Supplement2 page 304" href="http://viewer.zmags.com/publication/916a99fc?page=304"> 300A 1191 HE4 Has a Role in Treatment Planning</a> <a title="MPATH_Vol.29_Supplement2 page 305" href="http://viewer.zmags.com/publication/916a99fc?page=305"> ANNUAL MEETING ABSTRACTS Results: All 26 IVL show</a> <a title="MPATH_Vol.29_Supplement2 page 306" href="http://viewer.zmags.com/publication/916a99fc?page=306"> 302A sectioning of tumor, normal endometrium, uni</a> <a title="MPATH_Vol.29_Supplement2 page 307" href="http://viewer.zmags.com/publication/916a99fc?page=307"> ANNUAL MEETING ABSTRACTS mutations distribution c</a> <a title="MPATH_Vol.29_Supplement2 page 308" href="http://viewer.zmags.com/publication/916a99fc?page=308"> 304A 1208 CD8, FoxP3 and CD45Ro Positive Tumor</a> <a title="MPATH_Vol.29_Supplement2 page 309" href="http://viewer.zmags.com/publication/916a99fc?page=309"> ANNUAL MEETING ABSTRACTS mucinous differentiation</a> <a title="MPATH_Vol.29_Supplement2 page 310" href="http://viewer.zmags.com/publication/916a99fc?page=310"> 306A Conclusions: PD-L1 expressio</a> <a title="MPATH_Vol.29_Supplement2 page 311" href="http://viewer.zmags.com/publication/916a99fc?page=311"> ANNUAL MEETING ABSTRACTS Table 1. Correlation of </a> <a title="MPATH_Vol.29_Supplement2 page 312" href="http://viewer.zmags.com/publication/916a99fc?page=312"> 308A group reclassified as HSIL (p<0.001). p16 wa</a> <a title="MPATH_Vol.29_Supplement2 page 313" href="http://viewer.zmags.com/publication/916a99fc?page=313"> ANNUAL MEETING ABSTRACTS lymphocytes (TILs) (0, n</a> <a title="MPATH_Vol.29_Supplement2 page 314" href="http://viewer.zmags.com/publication/916a99fc?page=314"> 310A Group Kappa score Kendall’s coefficient </a> <a title="MPATH_Vol.29_Supplement2 page 315" href="http://viewer.zmags.com/publication/916a99fc?page=315"> ANNUAL MEETING ABSTRACTS 1234 Serial Sectionin</a> <a title="MPATH_Vol.29_Supplement2 page 316" href="http://viewer.zmags.com/publication/916a99fc?page=316"> 312A was defined as H score 10 or higher for all </a> <a title="MPATH_Vol.29_Supplement2 page 317" href="http://viewer.zmags.com/publication/916a99fc?page=317"> ANNUAL MEETING ABSTRACTS endometrial sampling res</a> <a title="MPATH_Vol.29_Supplement2 page 318" href="http://viewer.zmags.com/publication/916a99fc?page=318"> 314A 1247 Classic Vulvar Intraepithelial Neopl</a> <a title="MPATH_Vol.29_Supplement2 page 319" href="http://viewer.zmags.com/publication/916a99fc?page=319"> ANNUAL MEETING ABSTRACTS 1251 Systems Biology </a> <a title="MPATH_Vol.29_Supplement2 page 320" href="http://viewer.zmags.com/publication/916a99fc?page=320"> 316A Results: IPMC involved >5% of villi in 11 of</a> <a title="MPATH_Vol.29_Supplement2 page 321" href="http://viewer.zmags.com/publication/916a99fc?page=321"> ANNUAL MEETING ABSTRACTS 1259 Cutaneous Leishm</a> <a title="MPATH_Vol.29_Supplement2 page 322" href="http://viewer.zmags.com/publication/916a99fc?page=322"> 318A 1263 HPV-Induced HNSCC, All Locations Com</a> <a title="MPATH_Vol.29_Supplement2 page 323" href="http://viewer.zmags.com/publication/916a99fc?page=323"> ANNUAL MEETING ABSTRACTS Results: Four cases of c</a> <a title="MPATH_Vol.29_Supplement2 page 324" href="http://viewer.zmags.com/publication/916a99fc?page=324"> 320A follow-up, 13 developed recurrence. Tumors w</a> <a title="MPATH_Vol.29_Supplement2 page 325" href="http://viewer.zmags.com/publication/916a99fc?page=325"> ANNUAL MEETING ABSTRACTS layer) and immunophenoty</a> <a title="MPATH_Vol.29_Supplement2 page 326" href="http://viewer.zmags.com/publication/916a99fc?page=326"> 322A Conclusions: Despite its known impact on pro</a> <a title="MPATH_Vol.29_Supplement2 page 327" href="http://viewer.zmags.com/publication/916a99fc?page=327"> ANNUAL MEETING ABSTRACTS 1281 Abstract Withdra</a> <a title="MPATH_Vol.29_Supplement2 page 328" href="http://viewer.zmags.com/publication/916a99fc?page=328"> 324A architecture (p= 0.05). Lymphoepithelial mor</a> <a title="MPATH_Vol.29_Supplement2 page 329" href="http://viewer.zmags.com/publication/916a99fc?page=329"> ANNUAL MEETING ABSTRACTS 1289 Clinicopathologi</a> <a title="MPATH_Vol.29_Supplement2 page 330" href="http://viewer.zmags.com/publication/916a99fc?page=330"> 326A oncocytic and mucinous variants were seen. T</a> <a title="MPATH_Vol.29_Supplement2 page 331" href="http://viewer.zmags.com/publication/916a99fc?page=331"> ANNUAL MEETING ABSTRACTS 1298 Investigation of</a> <a title="MPATH_Vol.29_Supplement2 page 332" href="http://viewer.zmags.com/publication/916a99fc?page=332"> 328A Design: We assessed the expression of MYB an</a> <a title="MPATH_Vol.29_Supplement2 page 333" href="http://viewer.zmags.com/publication/916a99fc?page=333"> ANNUAL MEETING ABSTRACTS A strong ISH score (3+/2</a> <a title="MPATH_Vol.29_Supplement2 page 334" href="http://viewer.zmags.com/publication/916a99fc?page=334"> 330A 1311 Comparison of p16 Antibody Clones fo</a> <a title="MPATH_Vol.29_Supplement2 page 335" href="http://viewer.zmags.com/publication/916a99fc?page=335"> ANNUAL MEETING ABSTRACTS Conclusions: We demonstr</a> <a title="MPATH_Vol.29_Supplement2 page 336" href="http://viewer.zmags.com/publication/916a99fc?page=336"> 332A 1319 Prognostic Histological Features in </a> <a title="MPATH_Vol.29_Supplement2 page 337" href="http://viewer.zmags.com/publication/916a99fc?page=337"> ANNUAL MEETING ABSTRACTS carcinoma in situ (CIS) </a> <a title="MPATH_Vol.29_Supplement2 page 338" href="http://viewer.zmags.com/publication/916a99fc?page=338"> 334A and 10 <50%. 2/4 with c-MYC >50% were positi</a> <a title="MPATH_Vol.29_Supplement2 page 339" href="http://viewer.zmags.com/publication/916a99fc?page=339"> ANNUAL MEETING ABSTRACTS in the aMCL group (18 vs</a> <a title="MPATH_Vol.29_Supplement2 page 340" href="http://viewer.zmags.com/publication/916a99fc?page=340"> 336A The goal of this study was to: 1- Determine </a> <a title="MPATH_Vol.29_Supplement2 page 341" href="http://viewer.zmags.com/publication/916a99fc?page=341"> ANNUAL MEETING ABSTRACTS </a> <a title="MPATH_Vol.29_Supplement2 page 342" href="http://viewer.zmags.com/publication/916a99fc?page=342"> 338A harbored an MYD88 mutation supporting a diag</a> <a title="MPATH_Vol.29_Supplement2 page 343" href="http://viewer.zmags.com/publication/916a99fc?page=343"> ANNUAL MEETING ABSTRACTS following formula: % red</a> <a title="MPATH_Vol.29_Supplement2 page 344" href="http://viewer.zmags.com/publication/916a99fc?page=344"> 340A IDHm in AML. Furthermore, the D/L ratio may </a> <a title="MPATH_Vol.29_Supplement2 page 345" href="http://viewer.zmags.com/publication/916a99fc?page=345"> ANNUAL MEETING ABSTRACTS Results: Among 108 DLBCL</a> <a title="MPATH_Vol.29_Supplement2 page 346" href="http://viewer.zmags.com/publication/916a99fc?page=346"> 342A Conclusions: Our results</a> <a title="MPATH_Vol.29_Supplement2 page 347" href="http://viewer.zmags.com/publication/916a99fc?page=347"> ANNUAL MEETING ABSTRACTS 1359 Gray Zone Lympho</a> <a title="MPATH_Vol.29_Supplement2 page 348" href="http://viewer.zmags.com/publication/916a99fc?page=348"> 344A on 36 cases, including 27 DLBCLs, and patter</a> <a title="MPATH_Vol.29_Supplement2 page 349" href="http://viewer.zmags.com/publication/916a99fc?page=349"> ANNUAL MEETING ABSTRACTS forceps in RPMI-1640 med</a> <a title="MPATH_Vol.29_Supplement2 page 350" href="http://viewer.zmags.com/publication/916a99fc?page=350"> 346A 1371 PD-1/PD-L1 Are Novel Therapeutic Tar</a> <a title="MPATH_Vol.29_Supplement2 page 351" href="http://viewer.zmags.com/publication/916a99fc?page=351"> ANNUAL MEETING ABSTRACTS Genes No. of cases </a> <a title="MPATH_Vol.29_Supplement2 page 352" href="http://viewer.zmags.com/publication/916a99fc?page=352"> 348A t-CMML, and 1 t-AML); 18 patients had a morp</a> <a title="MPATH_Vol.29_Supplement2 page 353" href="http://viewer.zmags.com/publication/916a99fc?page=353"> ANNUAL MEETING ABSTRACTS 1381 Plasma Cells in </a> <a title="MPATH_Vol.29_Supplement2 page 354" href="http://viewer.zmags.com/publication/916a99fc?page=354"> 350A percentage of positive platelets, often with</a> <a title="MPATH_Vol.29_Supplement2 page 355" href="http://viewer.zmags.com/publication/916a99fc?page=355"> ANNUAL MEETING ABSTRACTS Genes Number of Case</a> <a title="MPATH_Vol.29_Supplement2 page 356" href="http://viewer.zmags.com/publication/916a99fc?page=356"> 352A 1391 Mutation Analysis in 45 Cases of New</a> <a title="MPATH_Vol.29_Supplement2 page 357" href="http://viewer.zmags.com/publication/916a99fc?page=357"> ANNUAL MEETING ABSTRACTS 1394 Clinical Deep Se</a> <a title="MPATH_Vol.29_Supplement2 page 358" href="http://viewer.zmags.com/publication/916a99fc?page=358"> 354A 1398 AID-Generated IGH Glycosylation Site</a> <a title="MPATH_Vol.29_Supplement2 page 359" href="http://viewer.zmags.com/publication/916a99fc?page=359"> ANNUAL MEETING ABSTRACTS 1402 Proliferation Ce</a> <a title="MPATH_Vol.29_Supplement2 page 360" href="http://viewer.zmags.com/publication/916a99fc?page=360"> 356A 1406 Langerhans Cell Histiocytosis Exp</a> <a title="MPATH_Vol.29_Supplement2 page 361" href="http://viewer.zmags.com/publication/916a99fc?page=361"> ANNUAL MEETING ABSTRACTS 2 criteria although BM m</a> <a title="MPATH_Vol.29_Supplement2 page 362" href="http://viewer.zmags.com/publication/916a99fc?page=362"> 358A involving either genes share similar patholo</a> <a title="MPATH_Vol.29_Supplement2 page 363" href="http://viewer.zmags.com/publication/916a99fc?page=363"> ANNUAL MEETING ABSTRACTS 1417 Objective Quanti</a> <a title="MPATH_Vol.29_Supplement2 page 364" href="http://viewer.zmags.com/publication/916a99fc?page=364"> 360A by immunohistochemistry (IHC) has not been s</a> <a title="MPATH_Vol.29_Supplement2 page 365" href="http://viewer.zmags.com/publication/916a99fc?page=365"> ANNUAL MEETING ABSTRACTS It is noteworthy that BC</a> <a title="MPATH_Vol.29_Supplement2 page 366" href="http://viewer.zmags.com/publication/916a99fc?page=366"> 362A Design: We assessed levels of mRNAs encoding</a> <a title="MPATH_Vol.29_Supplement2 page 367" href="http://viewer.zmags.com/publication/916a99fc?page=367"> ANNUAL MEETING ABSTRACTS falsely negative in the </a> <a title="MPATH_Vol.29_Supplement2 page 368" href="http://viewer.zmags.com/publication/916a99fc?page=368"> 364A (40%). Ki67 proliferation index was lower (6</a> <a title="MPATH_Vol.29_Supplement2 page 369" href="http://viewer.zmags.com/publication/916a99fc?page=369"> ANNUAL MEETING ABSTRACTS reactive large granular </a> <a title="MPATH_Vol.29_Supplement2 page 370" href="http://viewer.zmags.com/publication/916a99fc?page=370"> 366A megakaryocytes. No difference in pattern was</a> <a title="MPATH_Vol.29_Supplement2 page 371" href="http://viewer.zmags.com/publication/916a99fc?page=371"> ANNUAL MEETING ABSTRACTS recovery with an average</a> <a title="MPATH_Vol.29_Supplement2 page 372" href="http://viewer.zmags.com/publication/916a99fc?page=372"> 368A Design: A retrospective survey of DLBCL case</a> <a title="MPATH_Vol.29_Supplement2 page 373" href="http://viewer.zmags.com/publication/916a99fc?page=373"> ANNUAL MEETING ABSTRACTS 1457 A Proposal for P</a> <a title="MPATH_Vol.29_Supplement2 page 374" href="http://viewer.zmags.com/publication/916a99fc?page=374"> 370A Conc</a> <a title="MPATH_Vol.29_Supplement2 page 375" href="http://viewer.zmags.com/publication/916a99fc?page=375"> ANNUAL MEETING ABSTRACTS by megakaryocytes; as we</a> <a title="MPATH_Vol.29_Supplement2 page 376" href="http://viewer.zmags.com/publication/916a99fc?page=376"> 372A 1467 Histologic and Corresponding Laborat</a> <a title="MPATH_Vol.29_Supplement2 page 377" href="http://viewer.zmags.com/publication/916a99fc?page=377"> ANNUAL MEETING ABSTRACTS the phenotypic and cytog</a> <a title="MPATH_Vol.29_Supplement2 page 378" href="http://viewer.zmags.com/publication/916a99fc?page=378"> 374A Conclusions: Presence of PD1 </a> <a title="MPATH_Vol.29_Supplement2 page 379" href="http://viewer.zmags.com/publication/916a99fc?page=379"> ANNUAL MEETING ABSTRACTS </a> <a title="MPATH_Vol.29_Supplement2 page 380" href="http://viewer.zmags.com/publication/916a99fc?page=380"> 376A Conclusions: In this st</a> <a title="MPATH_Vol.29_Supplement2 page 381" href="http://viewer.zmags.com/publication/916a99fc?page=381"> ANNUAL MEETING ABSTRACTS Age (mean [range]) </a> <a title="MPATH_Vol.29_Supplement2 page 382" href="http://viewer.zmags.com/publication/916a99fc?page=382"> 378A Independ</a> <a title="MPATH_Vol.29_Supplement2 page 383" href="http://viewer.zmags.com/publication/916a99fc?page=383"> ANNUAL MEETING ABSTRACTS 1493 Differential Exp</a> <a title="MPATH_Vol.29_Supplement2 page 384" href="http://viewer.zmags.com/publication/916a99fc?page=384"> 380A critical component of the MTORC2 complex req</a> <a title="MPATH_Vol.29_Supplement2 page 385" href="http://viewer.zmags.com/publication/916a99fc?page=385"> ANNUAL MEETING ABSTRACTS Conclusi</a> <a title="MPATH_Vol.29_Supplement2 page 386" href="http://viewer.zmags.com/publication/916a99fc?page=386"> 382A splicing, and chromatin remodeling are mecha</a> <a title="MPATH_Vol.29_Supplement2 page 387" href="http://viewer.zmags.com/publication/916a99fc?page=387"> ANNUAL MEETING ABSTRACTS the sole presence of i(1</a> <a title="MPATH_Vol.29_Supplement2 page 388" href="http://viewer.zmags.com/publication/916a99fc?page=388"> 384A 1514 Integration of Multi-Locus DNA Methy</a> <a title="MPATH_Vol.29_Supplement2 page 389" href="http://viewer.zmags.com/publication/916a99fc?page=389"> ANNUAL MEETING ABSTRACTS Conclusions: Our series </a> <a title="MPATH_Vol.29_Supplement2 page 390" href="http://viewer.zmags.com/publication/916a99fc?page=390"> 386A (P<0.01) and a low p-AKT expression (P=0.03)</a> <a title="MPATH_Vol.29_Supplement2 page 391" href="http://viewer.zmags.com/publication/916a99fc?page=391"> ANNUAL MEETING ABSTRACTS 1527 Computerized Ima</a> <a title="MPATH_Vol.29_Supplement2 page 392" href="http://viewer.zmags.com/publication/916a99fc?page=392"> 388A HLA-DR, increased CD33, increased CD123, var</a> <a title="MPATH_Vol.29_Supplement2 page 393" href="http://viewer.zmags.com/publication/916a99fc?page=393"> ANNUAL MEETING ABSTRACTS 1536 Investigation of</a> <a title="MPATH_Vol.29_Supplement2 page 394" href="http://viewer.zmags.com/publication/916a99fc?page=394"> 390A bowel disease (IBD) or malignancy. Histologi</a> <a title="MPATH_Vol.29_Supplement2 page 395" href="http://viewer.zmags.com/publication/916a99fc?page=395"> ANNUAL MEETING ABSTRACTS positive for HSV-1/2 and</a> <a title="MPATH_Vol.29_Supplement2 page 396" href="http://viewer.zmags.com/publication/916a99fc?page=396"> 392A Results: A total of 52 survey responses were</a> <a title="MPATH_Vol.29_Supplement2 page 397" href="http://viewer.zmags.com/publication/916a99fc?page=397"> ANNUAL MEETING ABSTRACTS Furthermore, we have est</a> <a title="MPATH_Vol.29_Supplement2 page 398" href="http://viewer.zmags.com/publication/916a99fc?page=398"> 394A that has been linked to configural image int</a> <a title="MPATH_Vol.29_Supplement2 page 399" href="http://viewer.zmags.com/publication/916a99fc?page=399"> ANNUAL MEETING ABSTRACTS Conclusions: While the o</a> <a title="MPATH_Vol.29_Supplement2 page 400" href="http://viewer.zmags.com/publication/916a99fc?page=400"> 396A 1563 Validation of the Mobile Whole Slide</a> <a title="MPATH_Vol.29_Supplement2 page 401" href="http://viewer.zmags.com/publication/916a99fc?page=401"> ANNUAL MEETING ABSTRACTS </a> <a title="MPATH_Vol.29_Supplement2 page 402" href="http://viewer.zmags.com/publication/916a99fc?page=402"> 398A 1570 The Influence of </a> <a title="MPATH_Vol.29_Supplement2 page 403" href="http://viewer.zmags.com/publication/916a99fc?page=403"> ANNUAL MEETING ABSTRACTS Conclusions: Kaplan-Meri</a> <a title="MPATH_Vol.29_Supplement2 page 404" href="http://viewer.zmags.com/publication/916a99fc?page=404"> 400A are studied at specimen and case level and a</a> <a title="MPATH_Vol.29_Supplement2 page 405" href="http://viewer.zmags.com/publication/916a99fc?page=405"> ANNUAL MEETING ABSTRACTS Results: Table1 shows de</a> <a title="MPATH_Vol.29_Supplement2 page 406" href="http://viewer.zmags.com/publication/916a99fc?page=406"> 402A to be the most predictive in distinguishing </a> <a title="MPATH_Vol.29_Supplement2 page 407" href="http://viewer.zmags.com/publication/916a99fc?page=407"> ANNUAL MEETING ABSTRACTS by lesions associated wi</a> <a title="MPATH_Vol.29_Supplement2 page 408" href="http://viewer.zmags.com/publication/916a99fc?page=408"> 404A not different between IgA and IgA+IgG. Analy</a> <a title="MPATH_Vol.29_Supplement2 page 409" href="http://viewer.zmags.com/publication/916a99fc?page=409"> ANNUAL MEETING ABSTRACTS 1597 Dendritic Cells </a> <a title="MPATH_Vol.29_Supplement2 page 410" href="http://viewer.zmags.com/publication/916a99fc?page=410"> 406A 1601 Routine Clinical Use of Exome NGS fo</a> <a title="MPATH_Vol.29_Supplement2 page 411" href="http://viewer.zmags.com/publication/916a99fc?page=411"> ANNUAL MEETING ABSTRACTS Results: BKV was not det</a> <a title="MPATH_Vol.29_Supplement2 page 412" href="http://viewer.zmags.com/publication/916a99fc?page=412"> 408A Conclusions</a> <a title="MPATH_Vol.29_Supplement2 page 413" href="http://viewer.zmags.com/publication/916a99fc?page=413"> ANNUAL MEETING ABSTRACTS or equal to 18 years of </a> <a title="MPATH_Vol.29_Supplement2 page 414" href="http://viewer.zmags.com/publication/916a99fc?page=414"> 410A 1617 Renal Cell Carcinoma in Allograft Ki</a> <a title="MPATH_Vol.29_Supplement2 page 415" href="http://viewer.zmags.com/publication/916a99fc?page=415"> ANNUAL MEETING ABSTRACTS Results: Endo- carditi</a> <a title="MPATH_Vol.29_Supplement2 page 416" href="http://viewer.zmags.com/publication/916a99fc?page=416"> 412A 1624 PLA2R+ Membranous Nephropathy Has Gr</a> <a title="MPATH_Vol.29_Supplement2 page 417" href="http://viewer.zmags.com/publication/916a99fc?page=417"> ANNUAL MEETING ABSTRACTS prior to 1998 were exclu</a> <a title="MPATH_Vol.29_Supplement2 page 418" href="http://viewer.zmags.com/publication/916a99fc?page=418"> 414A Conclusions: LI-RADS category 4 and 5 lesion</a> <a title="MPATH_Vol.29_Supplement2 page 419" href="http://viewer.zmags.com/publication/916a99fc?page=419"> ANNUAL MEETING ABSTRACTS 1636 Unique Morpholog</a> <a title="MPATH_Vol.29_Supplement2 page 420" href="http://viewer.zmags.com/publication/916a99fc?page=420"> 416A 1639 Molecular and Cytogenomic Profiling o</a> <a title="MPATH_Vol.29_Supplement2 page 421" href="http://viewer.zmags.com/publication/916a99fc?page=421"> ANNUAL MEETING ABSTRACTS 1643 10% of Well Diff</a> <a title="MPATH_Vol.29_Supplement2 page 422" href="http://viewer.zmags.com/publication/916a99fc?page=422"> 418A the patients had hematological disorders, wi</a> <a title="MPATH_Vol.29_Supplement2 page 423" href="http://viewer.zmags.com/publication/916a99fc?page=423"> ANNUAL MEETING ABSTRACTS in a bile duct adenoma. </a> <a title="MPATH_Vol.29_Supplement2 page 424" href="http://viewer.zmags.com/publication/916a99fc?page=424"> 420A 1656 BSEP and MDR3: Useful Immunohistoche</a> <a title="MPATH_Vol.29_Supplement2 page 425" href="http://viewer.zmags.com/publication/916a99fc?page=425"> ANNUAL MEETING ABSTRACTS displayed multifocal sca</a> <a title="MPATH_Vol.29_Supplement2 page 426" href="http://viewer.zmags.com/publication/916a99fc?page=426"> 422A 1665 Hepar-1 Loss inTelangiectatic/Inflamm</a> <a title="MPATH_Vol.29_Supplement2 page 427" href="http://viewer.zmags.com/publication/916a99fc?page=427"> ANNUAL MEETING ABSTRACTS carcinoma (CCHCC). Arg s</a> <a title="MPATH_Vol.29_Supplement2 page 428" href="http://viewer.zmags.com/publication/916a99fc?page=428"> 424A 1674 Are Eosinophilic Glassy Globules in </a> <a title="MPATH_Vol.29_Supplement2 page 429" href="http://viewer.zmags.com/publication/916a99fc?page=429"> ANNUAL MEETING ABSTRACTS This study examines the </a> <a title="MPATH_Vol.29_Supplement2 page 430" href="http://viewer.zmags.com/publication/916a99fc?page=430"> 426A require the coadministration of interferon (</a> <a title="MPATH_Vol.29_Supplement2 page 431" href="http://viewer.zmags.com/publication/916a99fc?page=431"> ANNUAL MEETING ABSTRACTS Hist</a> <a title="MPATH_Vol.29_Supplement2 page 432" href="http://viewer.zmags.com/publication/916a99fc?page=432"> 428A 1 large cell neuroendocrine carcinoma [LCNEC</a> <a title="MPATH_Vol.29_Supplement2 page 433" href="http://viewer.zmags.com/publication/916a99fc?page=433"> ANNUAL MEETING ABSTRACTS cholangiocarcinomas, 3 b</a> <a title="MPATH_Vol.29_Supplement2 page 434" href="http://viewer.zmags.com/publication/916a99fc?page=434"> 430A presence of BRAF GA. Multiple examples of cl</a> <a title="MPATH_Vol.29_Supplement2 page 435" href="http://viewer.zmags.com/publication/916a99fc?page=435"> ANNUAL MEETING ABSTRACTS SEGAs frequently show co</a> <a title="MPATH_Vol.29_Supplement2 page 436" href="http://viewer.zmags.com/publication/916a99fc?page=436"> 432A scored as 2 was found in 2/16 (12.5% for bot</a> <a title="MPATH_Vol.29_Supplement2 page 437" href="http://viewer.zmags.com/publication/916a99fc?page=437"> ANNUAL MEETING ABSTRACTS archives. Recurrent tumo</a> <a title="MPATH_Vol.29_Supplement2 page 438" href="http://viewer.zmags.com/publication/916a99fc?page=438"> 434A being pursued as a predictive marker for tum</a> <a title="MPATH_Vol.29_Supplement2 page 439" href="http://viewer.zmags.com/publication/916a99fc?page=439"> ANNUAL MEETING ABSTRACTS required for successful </a> <a title="MPATH_Vol.29_Supplement2 page 440" href="http://viewer.zmags.com/publication/916a99fc?page=440"> 436A 40 years), because of their rarity, have bee</a> <a title="MPATH_Vol.29_Supplement2 page 441" href="http://viewer.zmags.com/publication/916a99fc?page=441"> ANNUAL MEETING ABSTRACTS mutations, associated wi</a> <a title="MPATH_Vol.29_Supplement2 page 442" href="http://viewer.zmags.com/publication/916a99fc?page=442"> 438A 1735 Pten Deletion Synergizes with Tp53 M</a> <a title="MPATH_Vol.29_Supplement2 page 443" href="http://viewer.zmags.com/publication/916a99fc?page=443"> ANNUAL MEETING ABSTRACTS Con</a> <a title="MPATH_Vol.29_Supplement2 page 444" href="http://viewer.zmags.com/publication/916a99fc?page=444"> 440A 1743 Molecular Profile of Pancreas Ductal</a> <a title="MPATH_Vol.29_Supplement2 page 445" href="http://viewer.zmags.com/publication/916a99fc?page=445"> ANNUAL MEETING ABSTRACTS 1747 Quasimesenchymal</a> <a title="MPATH_Vol.29_Supplement2 page 446" href="http://viewer.zmags.com/publication/916a99fc?page=446"> 442A 1751 The Predictive Effect of Human Equil</a> <a title="MPATH_Vol.29_Supplement2 page 447" href="http://viewer.zmags.com/publication/916a99fc?page=447"> ANNUAL MEETING ABSTRACTS analysis, median disease</a> <a title="MPATH_Vol.29_Supplement2 page 448" href="http://viewer.zmags.com/publication/916a99fc?page=448"> 444A anti-IDHR132H IHC on all cases with appropri</a> <a title="MPATH_Vol.29_Supplement2 page 449" href="http://viewer.zmags.com/publication/916a99fc?page=449"> ANNUAL MEETING ABSTRACTS Definition of R0 status </a> <a title="MPATH_Vol.29_Supplement2 page 450" href="http://viewer.zmags.com/publication/916a99fc?page=450"> 446A Conclusions: Pancreatic OGCs</a> <a title="MPATH_Vol.29_Supplement2 page 451" href="http://viewer.zmags.com/publication/916a99fc?page=451"> ANNUAL MEETING ABSTRACTS than in UC (3/19). In on</a> <a title="MPATH_Vol.29_Supplement2 page 452" href="http://viewer.zmags.com/publication/916a99fc?page=452"> 448A Design: We retrospectively reviewed slides f</a> <a title="MPATH_Vol.29_Supplement2 page 453" href="http://viewer.zmags.com/publication/916a99fc?page=453"> ANNUAL MEETING ABSTRACTS an attractive target for</a> <a title="MPATH_Vol.29_Supplement2 page 454" href="http://viewer.zmags.com/publication/916a99fc?page=454"> 450A expression between juxta-tumoral and tumor-r</a> <a title="MPATH_Vol.29_Supplement2 page 455" href="http://viewer.zmags.com/publication/916a99fc?page=455"> ANNUAL MEETING ABSTRACTS # Cases (% Total) </a> <a title="MPATH_Vol.29_Supplement2 page 456" href="http://viewer.zmags.com/publication/916a99fc?page=456"> 452A 1788 Are the Genomics in the Cancer Genom</a> <a title="MPATH_Vol.29_Supplement2 page 457" href="http://viewer.zmags.com/publication/916a99fc?page=457"> ANNUAL MEETING ABSTRACTS broader mutational profi</a> <a title="MPATH_Vol.29_Supplement2 page 458" href="http://viewer.zmags.com/publication/916a99fc?page=458"> 454A (14.7%) were reflexed to PP; of these, 176 w</a> <a title="MPATH_Vol.29_Supplement2 page 459" href="http://viewer.zmags.com/publication/916a99fc?page=459"> ANNUAL MEETING ABSTRACTS 1801 Recurrent, Trunc</a> <a title="MPATH_Vol.29_Supplement2 page 460" href="http://viewer.zmags.com/publication/916a99fc?page=460"> 456A using qPCR methods. Each NGS library prep in</a> <a title="MPATH_Vol.29_Supplement2 page 461" href="http://viewer.zmags.com/publication/916a99fc?page=461"> ANNUAL MEETING ABSTRACTS 1808 Up-regulated S10</a> <a title="MPATH_Vol.29_Supplement2 page 462" href="http://viewer.zmags.com/publication/916a99fc?page=462"> 458A rearrangements. The overall mutational profi</a> <a title="MPATH_Vol.29_Supplement2 page 463" href="http://viewer.zmags.com/publication/916a99fc?page=463"> ANNUAL MEETING ABSTRACTS Desi</a> <a title="MPATH_Vol.29_Supplement2 page 464" href="http://viewer.zmags.com/publication/916a99fc?page=464"> 460A 1820 Platelet Cloaking Maintains Migrator</a> <a title="MPATH_Vol.29_Supplement2 page 465" href="http://viewer.zmags.com/publication/916a99fc?page=465"> ANNUAL MEETING ABSTRACTS of the different isoform</a> <a title="MPATH_Vol.29_Supplement2 page 466" href="http://viewer.zmags.com/publication/916a99fc?page=466"> 462A 1829 Shifts in Mutation Profiles between P</a> <a title="MPATH_Vol.29_Supplement2 page 467" href="http://viewer.zmags.com/publication/916a99fc?page=467"> ANNUAL MEETING ABSTRACTS Transferase (TdT) positi</a> <a title="MPATH_Vol.29_Supplement2 page 468" href="http://viewer.zmags.com/publication/916a99fc?page=468"> 464A Table 1. Clinical findings Patient number Ge</a> <a title="MPATH_Vol.29_Supplement2 page 469" href="http://viewer.zmags.com/publication/916a99fc?page=469"> ANNUAL MEETING ABSTRACTS specificity for V600E. S</a> <a title="MPATH_Vol.29_Supplement2 page 470" href="http://viewer.zmags.com/publication/916a99fc?page=470"> 466A Histopathological study on metastatic lesion</a> <a title="MPATH_Vol.29_Supplement2 page 471" href="http://viewer.zmags.com/publication/916a99fc?page=471"> ANNUAL MEETING ABSTRACTS Pulmon</a> <a title="MPATH_Vol.29_Supplement2 page 472" href="http://viewer.zmags.com/publication/916a99fc?page=472"> 468A 1853 Clinical Utility of Targeted Next Ge</a> <a title="MPATH_Vol.29_Supplement2 page 473" href="http://viewer.zmags.com/publication/916a99fc?page=473"> ANNUAL MEETING ABSTRACTS analysis was also perfor</a> <a title="MPATH_Vol.29_Supplement2 page 474" href="http://viewer.zmags.com/publication/916a99fc?page=474"> 470A sCTLA-4 levels in PE were found ≥ 67 pg/ml (</a> <a title="MPATH_Vol.29_Supplement2 page 475" href="http://viewer.zmags.com/publication/916a99fc?page=475"> ANNUAL MEETING ABSTRACTS Design: We reviewed 247 </a> <a title="MPATH_Vol.29_Supplement2 page 476" href="http://viewer.zmags.com/publication/916a99fc?page=476"> 472A 1870 Non-neoplastic Pulmonary Parenchymal</a> <a title="MPATH_Vol.29_Supplement2 page 477" href="http://viewer.zmags.com/publication/916a99fc?page=477"> ANNUAL MEETING ABSTRACTS necrosis (HR 7.76, 95%CI</a> <a title="MPATH_Vol.29_Supplement2 page 478" href="http://viewer.zmags.com/publication/916a99fc?page=478"> 474A Only cases with surgical follow-up were sele</a> <a title="MPATH_Vol.29_Supplement2 page 479" href="http://viewer.zmags.com/publication/916a99fc?page=479"> ANNUAL MEETING ABSTRACTS respectively. This incre</a> <a title="MPATH_Vol.29_Supplement2 page 480" href="http://viewer.zmags.com/publication/916a99fc?page=480"> 476A 1888 Programmed Death 1 (PD-1) and PD-L1 </a> <a title="MPATH_Vol.29_Supplement2 page 481" href="http://viewer.zmags.com/publication/916a99fc?page=481"> ANNUAL MEETING ABSTRACTS Results: Among the 35 ca</a> <a title="MPATH_Vol.29_Supplement2 page 482" href="http://viewer.zmags.com/publication/916a99fc?page=482"> 478A Design: OTP immunohistochemistry was perform</a> <a title="MPATH_Vol.29_Supplement2 page 483" href="http://viewer.zmags.com/publication/916a99fc?page=483"> ANNUAL MEETING ABSTRACTS Conclusions: This study </a> <a title="MPATH_Vol.29_Supplement2 page 484" href="http://viewer.zmags.com/publication/916a99fc?page=484"> 480A Design: All surgical resection cases (exclud</a> <a title="MPATH_Vol.29_Supplement2 page 485" href="http://viewer.zmags.com/publication/916a99fc?page=485"> ANNUAL MEETING ABSTRACTS Conclusions: LCNEC is a </a> <a title="MPATH_Vol.29_Supplement2 page 486" href="http://viewer.zmags.com/publication/916a99fc?page=486"> 482A approach using paired 2x101bp reads). The se</a> <a title="MPATH_Vol.29_Supplement2 page 487" href="http://viewer.zmags.com/publication/916a99fc?page=487"> ANNUAL MEETING ABSTRACTS 1919 Programmed Cell </a> <a title="MPATH_Vol.29_Supplement2 page 488" href="http://viewer.zmags.com/publication/916a99fc?page=488"> 484A correlation between airway centered neutroph</a> <a title="MPATH_Vol.29_Supplement2 page 489" href="http://viewer.zmags.com/publication/916a99fc?page=489"> ANNUAL MEETING ABSTRACTS adenosquamous carcinomas</a> <a title="MPATH_Vol.29_Supplement2 page 490" href="http://viewer.zmags.com/publication/916a99fc?page=490"> 486A 65.6 years, p=0.01), less frequently smokers</a> <a title="MPATH_Vol.29_Supplement2 page 491" href="http://viewer.zmags.com/publication/916a99fc?page=491"> ANNUAL MEETING ABSTRACTS 1937 Pleomorphic Carc</a> <a title="MPATH_Vol.29_Supplement2 page 492" href="http://viewer.zmags.com/publication/916a99fc?page=492"> 488A Conclusions: The patients with solid or MPP </a> <a title="MPATH_Vol.29_Supplement2 page 493" href="http://viewer.zmags.com/publication/916a99fc?page=493"> ANNUAL MEETING ABSTRACTS patients were identified</a> <a title="MPATH_Vol.29_Supplement2 page 494" href="http://viewer.zmags.com/publication/916a99fc?page=494"> 490A review (semiquantitative without imaging sof</a> <a title="MPATH_Vol.29_Supplement2 page 495" href="http://viewer.zmags.com/publication/916a99fc?page=495"> ANNUAL MEETING ABSTRACTS Design: All respiratory </a> <a title="MPATH_Vol.29_Supplement2 page 496" href="http://viewer.zmags.com/publication/916a99fc?page=496"> 492A Results: H&Es of 99 cores from 33 patients w</a> <a title="MPATH_Vol.29_Supplement2 page 497" href="http://viewer.zmags.com/publication/916a99fc?page=497"> ANNUAL MEETING ABSTRACTS 1960 Quality Assuranc</a> <a title="MPATH_Vol.29_Supplement2 page 498" href="http://viewer.zmags.com/publication/916a99fc?page=498"> 494A critical to avoid misinterpretation. In an i</a> <a title="MPATH_Vol.29_Supplement2 page 499" href="http://viewer.zmags.com/publication/916a99fc?page=499"> ANNUAL MEETING ABSTRACTS 494 tissue blocks from 1</a> <a title="MPATH_Vol.29_Supplement2 page 500" href="http://viewer.zmags.com/publication/916a99fc?page=500"> 496A 1973 Validation of Digital Whole Slide Im</a> <a title="MPATH_Vol.29_Supplement2 page 501" href="http://viewer.zmags.com/publication/916a99fc?page=501"> ANNUAL MEETING ABSTRACTS IPCs should only be used</a> <a title="MPATH_Vol.29_Supplement2 page 502" href="http://viewer.zmags.com/publication/916a99fc?page=502"> 498A 1981 Osteomyelitis and Lower Extremity Am</a> <a title="MPATH_Vol.29_Supplement2 page 503" href="http://viewer.zmags.com/publication/916a99fc?page=503"> ANNUAL MEETING ABSTRACTS 1985 Bone Marrow Biop</a> <a title="MPATH_Vol.29_Supplement2 page 504" href="http://viewer.zmags.com/publication/916a99fc?page=504"> 500A probes demonstrated high specificities. Over</a> <a title="MPATH_Vol.29_Supplement2 page 505" href="http://viewer.zmags.com/publication/916a99fc?page=505"> ANNUAL MEETING ABSTRACTS involvement. Recent stud</a> <a title="MPATH_Vol.29_Supplement2 page 506" href="http://viewer.zmags.com/publication/916a99fc?page=506"> 502A 1995 Single Versus Multiple Levels for Ro</a> <a title="MPATH_Vol.29_Supplement2 page 507" href="http://viewer.zmags.com/publication/916a99fc?page=507"> ANNUAL MEETING ABSTRACTS sloughed cells and poorl</a> <a title="MPATH_Vol.29_Supplement2 page 508" href="http://viewer.zmags.com/publication/916a99fc?page=508"> 504A The estimated annualized monetary savings as</a> <a title="MPATH_Vol.29_Supplement2 page 509" href="http://viewer.zmags.com/publication/916a99fc?page=509"> ANNUAL MEETING ABSTRACTS 2007 Napsin Expressio</a> <a title="MPATH_Vol.29_Supplement2 page 510" href="http://viewer.zmags.com/publication/916a99fc?page=510"> 506A Design: Cases submitted to the Irish Nationa</a> <a title="MPATH_Vol.29_Supplement2 page 511" href="http://viewer.zmags.com/publication/916a99fc?page=511"> ANNUAL MEETING ABSTRACTS 2015 A Q</a> <a title="MPATH_Vol.29_Supplement2 page 512" href="http://viewer.zmags.com/publication/916a99fc?page=512"> 508A 2019 Intraoperative Evaluation of Borderl</a> <a title="MPATH_Vol.29_Supplement2 page 513" href="http://viewer.zmags.com/publication/916a99fc?page=513"> ANNUAL MEETING ABSTRACTS 2022 Quick Review of </a> <a title="MPATH_Vol.29_Supplement2 page 514" href="http://viewer.zmags.com/publication/916a99fc?page=514"> 510A 2026 RNAscope® 2.5: A Robust and High Per</a> <a title="MPATH_Vol.29_Supplement2 page 515" href="http://viewer.zmags.com/publication/916a99fc?page=515"> ANNUAL MEETING ABSTRACTS 2030 Fusion Gene Dete</a> <a title="MPATH_Vol.29_Supplement2 page 516" href="http://viewer.zmags.com/publication/916a99fc?page=516"> 512A panCK. However, CTCs entering the vasculatur</a> <a title="MPATH_Vol.29_Supplement2 page 517" href="http://viewer.zmags.com/publication/916a99fc?page=517"> ANNUAL MEETING ABSTRACTS LN only submitted </a> <a title="MPATH_Vol.29_Supplement2 page 518" href="http://viewer.zmags.com/publication/916a99fc?page=518"> 514A 2040 In Situ Evaluation of Telomerase Exp</a> <a title="MPATH_Vol.29_Supplement2 page 519" href="http://viewer.zmags.com/publication/916a99fc?page=519"> ANNUAL MEETING ABSTRACTS 2044 A Novel, Rapid, </a> <a title="MPATH_Vol.29_Supplement2 page 520" href="http://viewer.zmags.com/publication/916a99fc?page=520"> 516A Design: Histologic slides of 70 invasive duc</a> <a title="MPATH_Vol.29_Supplement2 page 521" href="http://viewer.zmags.com/publication/916a99fc?page=521"> ANNUAL MEETING ABSTRACTS Conclusions: These resul</a> <a title="MPATH_Vol.29_Supplement2 page 522" href="http://viewer.zmags.com/publication/916a99fc?page=522"> 518A Design: Twenty lung cancer sections and a lu</a> <a title="MPATH_Vol.29_Supplement2 page 523" href="http://viewer.zmags.com/publication/916a99fc?page=523"> ANNUAL MEETING ABSTRACTS The average QFI™ Score f</a> <a title="MPATH_Vol.29_Supplement2 page 524" href="http://viewer.zmags.com/publication/916a99fc?page=524"> 520A scraped) and mean (range) number of 10-micro</a> <a title="MPATH_Vol.29_Supplement2 page 525" href="http://viewer.zmags.com/publication/916a99fc?page=525"> ANNUAL MEETING ABSTRACTS Conclusi</a> <a title="MPATH_Vol.29_Supplement2 page 526" href="http://viewer.zmags.com/publication/916a99fc?page=526"> 522A </a> <a title="MPATH_Vol.29_Supplement2 page 527" href="http://viewer.zmags.com/publication/916a99fc?page=527"> ANNUAL MEETING ABSTRACTS and ERBB2 yielded identi</a> <a title="MPATH_Vol.29_Supplement2 page 528" href="http://viewer.zmags.com/publication/916a99fc?page=528"> 524A 2080 Digital Image Analysis Requires the </a> <a title="MPATH_Vol.29_Supplement2 page 529" href="http://viewer.zmags.com/publication/916a99fc?page=529"> ANNUAL MEETING ABSTRACTS Results: Novodiax’s Poly</a> <a title="MPATH_Vol.29_Supplement2 page 530" href="http://viewer.zmags.com/publication/916a99fc?page=530"> 526A 2088 Drug Induced Phospholipidosis in Kid</a> <a title="MPATH_Vol.29_Supplement2 page 531" href="http://viewer.zmags.com/publication/916a99fc?page=531"> ANNUAL MEETING ABSTRACTS </a> <a title="MPATH_Vol.29_Supplement2 page 532" href="http://viewer.zmags.com/publication/916a99fc?page=532"> Index of Abstract Authors Aamelfot, Christina ..</a> <a title="MPATH_Vol.29_Supplement2 page 533" href="http://viewer.zmags.com/publication/916a99fc?page=533"> Angevin, Eric ............................. 1822 </a> <a title="MPATH_Vol.29_Supplement2 page 534" href="http://viewer.zmags.com/publication/916a99fc?page=534"> Beach, Jordan R ......................... 1800 Be</a> <a title="MPATH_Vol.29_Supplement2 page 535" href="http://viewer.zmags.com/publication/916a99fc?page=535"> Brogi, Edi.... 201, 252, 253, 259, 268, </a> <a title="MPATH_Vol.29_Supplement2 page 536" href="http://viewer.zmags.com/publication/916a99fc?page=536"> Chaubey, Alka ... 71, 508, 1409, 1711, </a> <a title="MPATH_Vol.29_Supplement2 page 537" href="http://viewer.zmags.com/publication/916a99fc?page=537"> Contra, Jessie ............................. 1962</a> <a title="MPATH_Vol.29_Supplement2 page 538" href="http://viewer.zmags.com/publication/916a99fc?page=538"> Dias, Leonardo ........................... 1737 D</a> <a title="MPATH_Vol.29_Supplement2 page 539" href="http://viewer.zmags.com/publication/916a99fc?page=539"> Farmer, Peter .................... 1143, 1218 Far</a> <a title="MPATH_Vol.29_Supplement2 page 540" href="http://viewer.zmags.com/publication/916a99fc?page=540"> Gao, Sizhi P.................................. 84</a> <a title="MPATH_Vol.29_Supplement2 page 541" href="http://viewer.zmags.com/publication/916a99fc?page=541"> Guda, Kishore .............................. 822 </a> <a title="MPATH_Vol.29_Supplement2 page 542" href="http://viewer.zmags.com/publication/916a99fc?page=542"> Hickey, Tyler .................................. </a> <a title="MPATH_Vol.29_Supplement2 page 543" href="http://viewer.zmags.com/publication/916a99fc?page=543"> Islam, Humayun ........................... 854 Is</a> <a title="MPATH_Vol.29_Supplement2 page 544" href="http://viewer.zmags.com/publication/916a99fc?page=544"> Kawa, Shigeyuki .............. 1768, 1769 Kawabat</a> <a title="MPATH_Vol.29_Supplement2 page 545" href="http://viewer.zmags.com/publication/916a99fc?page=545"> Krishna, Murli ............................ 1686 </a> <a title="MPATH_Vol.29_Supplement2 page 546" href="http://viewer.zmags.com/publication/916a99fc?page=546"> Lew, Madelyn ...................... 422, 467 Lewa</a> <a title="MPATH_Vol.29_Supplement2 page 547" href="http://viewer.zmags.com/publication/916a99fc?page=547"> Luthra, Rajyalakshmi .......... 444, 534, 721</a> <a title="MPATH_Vol.29_Supplement2 page 548" href="http://viewer.zmags.com/publication/916a99fc?page=548"> McCullough, Debbie............ 113, 868 McDaniel,</a> <a title="MPATH_Vol.29_Supplement2 page 549" href="http://viewer.zmags.com/publication/916a99fc?page=549"> Moreira, A .................................. 189</a> <a title="MPATH_Vol.29_Supplement2 page 550" href="http://viewer.zmags.com/publication/916a99fc?page=550"> Nishio, Makoto .......................... 1915 Ni</a> <a title="MPATH_Vol.29_Supplement2 page 551" href="http://viewer.zmags.com/publication/916a99fc?page=551"> Parks, Eric R .............................. 1432</a> <a title="MPATH_Vol.29_Supplement2 page 552" href="http://viewer.zmags.com/publication/916a99fc?page=552"> Pusceddu, Sara ............................. 592 </a> <a title="MPATH_Vol.29_Supplement2 page 553" href="http://viewer.zmags.com/publication/916a99fc?page=553"> Rodriguez, Fausto ............ 1703, 1734 Rodrigu</a> <a title="MPATH_Vol.29_Supplement2 page 554" href="http://viewer.zmags.com/publication/916a99fc?page=554"> Savage, Amanda........................... 437 Sav</a> <a title="MPATH_Vol.29_Supplement2 page 555" href="http://viewer.zmags.com/publication/916a99fc?page=555"> Sibley, Richard K ......................... 114 S</a> <a title="MPATH_Vol.29_Supplement2 page 556" href="http://viewer.zmags.com/publication/916a99fc?page=556"> Sullivan, Megan ........................... 256 S</a> <a title="MPATH_Vol.29_Supplement2 page 557" href="http://viewer.zmags.com/publication/916a99fc?page=557"> Tracht, Jessica ............................ 1059</a> <a title="MPATH_Vol.29_Supplement2 page 558" href="http://viewer.zmags.com/publication/916a99fc?page=558"> Vujanic, Gordan ......................... 1841 Vu</a> <a title="MPATH_Vol.29_Supplement2 page 559" href="http://viewer.zmags.com/publication/916a99fc?page=559"> Woods, Tina ............................... 1299 </a> <a title="MPATH_Vol.29_Supplement2 page 560" href="http://viewer.zmags.com/publication/916a99fc?page=560"> Zehir, Ahmet ...... 64, 270, 1801, 1814 Zehnder, </a> <a title="MPATH_Vol.29_Supplement2 page 561" href="http://viewer.zmags.com/publication/916a99fc?page=561"> Abstract Name 4 Marie Christine Aub</a> <a title="MPATH_Vol.29_Supplement2 page 562" href="http://viewer.zmags.com/publication/916a99fc?page=562"> Abstract Name 293 Leisha Emens 300 </a> <a title="MPATH_Vol.29_Supplement2 page 563" href="http://viewer.zmags.com/publication/916a99fc?page=563"> Abstract Name 599 Erik K Alexander 609</a> <a title="MPATH_Vol.29_Supplement2 page 564" href="http://viewer.zmags.com/publication/916a99fc?page=564"> Abstract Name 799 Shabana F Pasha 806</a> <a title="MPATH_Vol.29_Supplement2 page 565" href="http://viewer.zmags.com/publication/916a99fc?page=565"> Abstract Name 976 Jason Law 976 </a> <a title="MPATH_Vol.29_Supplement2 page 566" href="http://viewer.zmags.com/publication/916a99fc?page=566"> Abstract Name 1045 Scott A Tomlins 104</a> <a title="MPATH_Vol.29_Supplement2 page 567" href="http://viewer.zmags.com/publication/916a99fc?page=567"> Abstract Name 1170 Brian Kudlow 1174 </a> <a title="MPATH_Vol.29_Supplement2 page 568" href="http://viewer.zmags.com/publication/916a99fc?page=568"> Abstract Name 1379 F Stephen Hodi 1379 </a> <a title="MPATH_Vol.29_Supplement2 page 569" href="http://viewer.zmags.com/publication/916a99fc?page=569"> Abstract Name 1516 Robert P Hasserjian 1</a> <a title="MPATH_Vol.29_Supplement2 page 570" href="http://viewer.zmags.com/publication/916a99fc?page=570"> Abstract Name 1584 Robert P Hasserjian 1</a> <a title="MPATH_Vol.29_Supplement2 page 571" href="http://viewer.zmags.com/publication/916a99fc?page=571"> Abstract Name 1795 Philip J Stephens 179</a> <a title="MPATH_Vol.29_Supplement2 page 572" href="http://viewer.zmags.com/publication/916a99fc?page=572"> Abstract Name 1900 Bruce E Johnson 1900 </a> <a title="MPATH_Vol.29_Supplement2 page 573" href="http://viewer.zmags.com/publication/916a99fc?page=573"> Abstract Name 2051 Xiao-Jun Ma 2051 </a> <a title="MPATH_Vol.29_Supplement2 page 574" href="http://viewer.zmags.com/publication/916a99fc?page=574"> Abstract Name Rele</a> <a title="MPATH_Vol.29_Supplement2 page 575" href="http://viewer.zmags.com/publication/916a99fc?page=575"> Diagnostic 2016 Pathology Update Pragmatic Approa</a> <a title="MPATH_Vol.29_Supplement2 page 576" href="http://viewer.zmags.com/publication/916a99fc?page=576"> Follow New Paths Yet Untraveled #USCAP2016 </a>